Frequencies for first 10,000 rows of pt variable in reac2006q3 dataset : 'Preferred Term'-level medical | terminology describing the event | Freq. Percent Cum. ----------------------------------------+----------------------------------- ABASIA | 11 0.11 0.11 ABDOMINAL ABSCESS | 3 0.03 0.14 ABDOMINAL DISCOMFORT | 9 0.09 0.23 ABDOMINAL DISTENSION | 10 0.10 0.33 ABDOMINAL HERNIA | 1 0.01 0.34 ABDOMINAL OPERATION | 1 0.01 0.35 ABDOMINAL PAIN | 53 0.53 0.88 ABDOMINAL PAIN LOWER | 5 0.05 0.93 ABDOMINAL PAIN UPPER | 19 0.19 1.12 ABDOMINAL STRANGULATED HERNIA | 1 0.01 1.13 ABDOMINAL TENDERNESS | 1 0.01 1.14 ABNORMAL BEHAVIOUR | 13 0.13 1.27 ABNORMAL DREAMS | 5 0.05 1.32 ABNORMAL FAECES | 4 0.04 1.36 ABNORMAL LABOUR | 3 0.03 1.39 ABNORMAL PALMAR/PLANTAR CREASES | 1 0.01 1.40 ABNORMAL SENSATION IN EYE | 1 0.01 1.41 ABNORMAL SLEEP-RELATED EVENT | 1 0.01 1.42 ABORTION | 2 0.02 1.44 ABORTION COMPLETE | 1 0.01 1.45 ABORTION INDUCED | 7 0.07 1.52 ABORTION MISSED | 2 0.02 1.54 ABORTION SPONTANEOUS | 26 0.26 1.80 ABORTION THREATENED | 1 0.01 1.81 ABSCESS | 3 0.03 1.84 ABSCESS DRAINAGE | 1 0.01 1.85 ABSCESS INTESTINAL | 1 0.01 1.86 ABULIA | 1 0.01 1.87 ACCIDENTAL EXPOSURE | 1 0.01 1.88 ACCIDENTAL NEEDLE STICK | 1 0.01 1.89 ACCIDENTAL OVERDOSE | 11 0.11 2.00 ACID BASE BALANCE ABNORMAL | 2 0.02 2.02 ACID FAST STAIN POSITIVE | 1 0.01 2.03 ACINETOBACTER INFECTION | 2 0.02 2.05 ACNE | 5 0.05 2.10 ACNE CYSTIC | 1 0.01 2.11 ACROCHORDON | 2 0.02 2.13 ACTINOMYCOSIS | 4 0.04 2.17 ACTIVATED PARTIAL THROMBOPLASTIN TIME.. | 2 0.02 2.19 ACTIVITIES OF DAILY LIVING IMPAIRED | 2 0.02 2.21 ACUTE ABDOMEN | 3 0.03 2.24 ACUTE CHEST SYNDROME | 1 0.01 2.25 ACUTE CORONARY SYNDROME | 1 0.01 2.26 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS | 1 0.01 2.27 ACUTE GENERALISED EXANTHEMATOUS PUSTU.. | 1 0.01 2.28 ACUTE LEUKAEMIA | 1 0.01 2.29 ACUTE MYOCARDIAL INFARCTION | 9 0.09 2.38 ACUTE PRERENAL FAILURE | 1 0.01 2.39 ACUTE PULMONARY OEDEMA | 2 0.02 2.41 ACUTE RESPIRATORY DISTRESS SYNDROME | 5 0.05 2.46 ACUTE SINUSITIS | 1 0.01 2.47 ADENOCARCINOMA | 1 0.01 2.48 ADENOMA BENIGN | 1 0.01 2.49 ADENOVIRUS INFECTION | 1 0.01 2.50 ADHESION | 1 0.01 2.51 ADJUSTMENT DISORDER | 1 0.01 2.52 ADJUSTMENT DISORDER WITH DEPRESSED MOOD | 1 0.01 2.53 ADRENAL CARCINOMA | 1 0.01 2.54 ADRENAL CORTICAL INSUFFICIENCY | 2 0.02 2.56 ADRENAL INSUFFICIENCY | 1 0.01 2.57 ADRENOGENITAL SYNDROME | 1 0.01 2.58 ADVERSE DRUG REACTION | 1 0.01 2.59 ADVERSE EVENT | 20 0.20 2.79 AFFECT LABILITY | 7 0.07 2.86 AFFECTIVE DISORDER | 1 0.01 2.87 AGEUSIA | 2 0.02 2.89 AGGRESSION | 11 0.11 3.00 AGITATION | 16 0.16 3.16 AGORAPHOBIA | 3 0.03 3.19 AGRANULOCYTOSIS | 9 0.09 3.28 AKATHISIA | 2 0.02 3.30 AKINESIA | 1 0.01 3.31 ALANINE AMINOTRANSFERASE | 1 0.01 3.32 ALANINE AMINOTRANSFERASE INCREASED | 67 0.67 3.99 ALBUMINURIA | 1 0.01 4.00 ALCOHOL POISONING | 1 0.01 4.01 ALCOHOL USE | 5 0.05 4.06 ALCOHOLISM | 2 0.02 4.08 ALLERGIC GRANULOMATOUS ANGIITIS | 2 0.02 4.10 ALLERGIC OEDEMA | 1 0.01 4.11 ALOPECIA | 11 0.11 4.22 ALPHA 1 FOETOPROTEIN AMNIOTIC FLUID I.. | 1 0.01 4.23 ALPHA 1 FOETOPROTEIN INCREASED | 1 0.01 4.24 ALPHA 1 GLOBULIN INCREASED | 3 0.03 4.27 ALPHA-1 ANTI-TRYPSIN INCREASED | 1 0.01 4.28 AMINO ACID LEVEL ABNORMAL | 1 0.01 4.29 AMMONIA INCREASED | 3 0.03 4.32 AMNESIA | 24 0.24 4.56 AMOEBIC DYSENTERY | 1 0.01 4.57 AMYOTROPHIC LATERAL SCLEROSIS | 1 0.01 4.58 ANAEMIA | 58 0.58 5.16 ANAEMIA MACROCYTIC | 1 0.01 5.17 ANAEMIA MEGALOBLASTIC | 1 0.01 5.18 ANAEMIA VITAMIN B12 DEFICIENCY | 2 0.02 5.20 ANAESTHESIA | 5 0.05 5.25 ANAL ATRESIA | 1 0.01 5.26 ANAL CANCER | 1 0.01 5.27 ANAL FISSURE | 3 0.03 5.30 ANAL FISTULA | 2 0.02 5.32 ANALGESIC DRUG LEVEL INCREASED | 1 0.01 5.33 ANAPHYLACTIC REACTION | 4 0.04 5.37 ANAPHYLACTIC SHOCK | 14 0.14 5.51 ANAPHYLACTOID REACTION | 3 0.03 5.54 ANAPLASTIC LARGE CELL LYMPHOMA T- AND.. | 1 0.01 5.55 ANEURYSM | 1 0.01 5.56 ANGER | 8 0.08 5.64 ANGINA PECTORIS | 9 0.09 5.73 ANGIOGRAM ABNORMAL | 1 0.01 5.74 ANGIONEUROTIC OEDEMA | 15 0.15 5.89 ANGIOPATHY | 3 0.03 5.92 ANGLE CLOSURE GLAUCOMA | 1 0.01 5.93 ANHEDONIA | 7 0.07 6.00 ANIMAL SCRATCH | 1 0.01 6.01 ANISOCYTOSIS | 1 0.01 6.02 ANKLE FRACTURE | 4 0.04 6.06 ANOGENITAL WARTS | 1 0.01 6.07 ANOMALY OF EXTERNAL EAR CONGENITAL | 1 0.01 6.08 ANORECTAL DISORDER | 1 0.01 6.09 ANOREXIA | 23 0.23 6.32 ANTEPARTUM HAEMORRHAGE | 2 0.02 6.34 ANTI-INSULIN ANTIBODY POSITIVE | 2 0.02 6.36 ANTIMITOCHONDRIAL ANTIBODY POSITIVE | 1 0.01 6.37 ANTINUCLEAR ANTIBODY INCREASED | 4 0.04 6.41 ANTINUCLEAR ANTIBODY POSITIVE | 5 0.05 6.46 ANTITHROMBIN III DECREASED | 1 0.01 6.47 ANURIA | 2 0.02 6.49 ANXIETY | 60 0.60 7.09 AORTA HYPOPLASIA | 1 0.01 7.10 AORTIC ANEURYSM | 1 0.01 7.11 AORTIC ARTERIOSCLEROSIS | 1 0.01 7.12 AORTIC DILATATION | 1 0.01 7.13 AORTIC DISSECTION | 2 0.02 7.15 AORTIC THROMBOSIS | 1 0.01 7.16 AORTIC VALVE INCOMPETENCE | 1 0.01 7.17 AORTIC VALVE SCLEROSIS | 1 0.01 7.18 AORTIC VALVE STENOSIS | 1 0.01 7.19 APATHY | 1 0.01 7.20 APHAGIA | 1 0.01 7.21 APHASIA | 7 0.07 7.28 APHONIA | 1 0.01 7.29 APHTHOUS STOMATITIS | 2 0.02 7.31 APLASIA PURE RED CELL | 4 0.04 7.35 APLASTIC ANAEMIA | 2 0.02 7.37 APNOEA | 5 0.05 7.42 APNOEIC ATTACK | 1 0.01 7.43 APPENDICECTOMY | 3 0.03 7.46 APPENDICITIS | 2 0.02 7.48 APPENDICITIS PERFORATED | 1 0.01 7.49 APPLICATION SITE BLEEDING | 1 0.01 7.50 APPLICATION SITE DERMATITIS | 1 0.01 7.51 APPLICATION SITE DISCOLOURATION | 1 0.01 7.52 APPLICATION SITE ERYTHEMA | 1 0.01 7.53 APPLICATION SITE PAIN | 1 0.01 7.54 APPLICATION SITE PRURITUS | 1 0.01 7.55 APPLICATION SITE REACTION | 1 0.01 7.56 APRAXIA | 2 0.02 7.58 ARNOLD-CHIARI MALFORMATION | 1 0.01 7.59 ARRHYTHMIA | 10 0.10 7.69 ARRHYTHMIA SUPRAVENTRICULAR | 1 0.01 7.70 ARTERIAL RUPTURE | 1 0.01 7.71 ARTERIAL THROMBOSIS | 1 0.01 7.72 ARTERIOSCLEROSIS | 2 0.02 7.74 ARTERIOSCLEROSIS CORONARY ARTERY | 2 0.02 7.76 ARTHRALGIA | 35 0.35 8.11 ARTHRITIS | 10 0.10 8.21 ARTHRITIS BACTERIAL | 1 0.01 8.22 ARTHRITIS INFECTIVE | 2 0.02 8.24 ARTHROPATHY | 4 0.04 8.28 ARTHROPOD BITE | 2 0.02 8.30 ARTHROPOD STING | 1 0.01 8.31 ASCITES | 11 0.11 8.42 ASPARTATE AMINOTRANSFERASE DECREASED | 1 0.01 8.43 ASPARTATE AMINOTRANSFERASE INCREASED | 71 0.71 9.14 ASPERGILLOSIS | 1 0.01 9.15 ASPIRATION | 3 0.03 9.18 ASTHENIA | 67 0.67 9.85 ASTHENOPIA | 1 0.01 9.86 ASTHMA | 11 0.11 9.97 ASTIGMATISM | 1 0.01 9.98 ATELECTASIS | 4 0.04 10.02 ATRIAL FIBRILLATION | 12 0.12 10.14 ATRIAL FLUTTER | 3 0.03 10.17 ATRIAL TACHYCARDIA | 1 0.01 10.18 ATRIOVENTRICULAR BLOCK | 1 0.01 10.19 ATRIOVENTRICULAR BLOCK FIRST DEGREE | 3 0.03 10.22 ATRIOVENTRICULAR BLOCK SECOND DEGREE | 1 0.01 10.23 ATRIOVENTRICULAR BLOCK THIRD DEGREE | 3 0.03 10.26 ATROPHY | 1 0.01 10.27 ATTENTION DEFICIT/HYPERACTIVITY DISOR.. | 2 0.02 10.29 ATYPICAL MYCOBACTERIAL INFECTION | 1 0.01 10.30 AUTOIMMUNE DISORDER | 5 0.05 10.35 AUTOIMMUNE HEPATITIS | 4 0.04 10.39 AUTOLOGOUS BONE MARROW TRANSPLANTATIO.. | 1 0.01 10.40 AUTOMATISM | 1 0.01 10.41 AUTONOMIC NEUROPATHY | 1 0.01 10.42 AZOTAEMIA | 1 0.01 10.43 B-CELL LYMPHOMA | 1 0.01 10.44 B-CELL LYMPHOMA RECURRENT | 1 0.01 10.45 B-CELL SMALL LYMPHOCYTIC LYMPHOMA | 2 0.02 10.47 BACK PAIN | 35 0.35 10.82 BACTERAEMIA | 2 0.02 10.84 BACTERIA URINE | 1 0.01 10.85 BACTERIAL INFECTION | 6 0.06 10.91 BACTERIAL SEPSIS | 1 0.01 10.92 BACTEROIDES INFECTION | 1 0.01 10.93 BALANCE DISORDER | 13 0.13 11.06 BALLISMUS | 1 0.01 11.07 BAND NEUTROPHIL COUNT DECREASED | 1 0.01 11.08 BASAL CELL CARCINOMA | 5 0.05 11.13 BASILAR ARTERY OCCLUSION | 1 0.01 11.14 BEDRIDDEN | 1 0.01 11.15 BENIGN INTRACRANIAL HYPERTENSION | 1 0.01 11.16 BENIGN NEOPLASM OF SKIN | 1 0.01 11.17 BILE DUCT CANCER | 1 0.01 11.18 BILE DUCT OBSTRUCTION | 1 0.01 11.19 BILE DUCT STONE | 1 0.01 11.20 BILIARY DILATATION | 1 0.01 11.21 BILIARY TRACT DISORDER | 3 0.03 11.24 BILIRUBIN CONJUGATED INCREASED | 4 0.04 11.28 BIOPSY BONE MARROW ABNORMAL | 2 0.02 11.30 BIOPSY KIDNEY ABNORMAL | 1 0.01 11.31 BIPOLAR DISORDER | 3 0.03 11.34 BIPOLAR I DISORDER | 2 0.02 11.36 BITE | 1 0.01 11.37 BLADDER CANCER | 2 0.02 11.39 BLADDER CANCER RECURRENT | 1 0.01 11.40 BLADDER DISORDER | 2 0.02 11.42 BLADDER PERFORATION | 1 0.01 11.43 BLADDER SPASM | 1 0.01 11.44 BLADDER TAMPONADE | 1 0.01 11.45 BLEPHARITIS | 2 0.02 11.47 BLEPHAROSPASM | 2 0.02 11.49 BLINDNESS | 14 0.14 11.63 BLINDNESS TRANSIENT | 3 0.03 11.66 BLINDNESS UNILATERAL | 3 0.03 11.69 BLISTER | 9 0.09 11.78 BLOOD 25-HYDROXYCHOLECALCIFEROL DECRE.. | 1 0.01 11.79 BLOOD ALBUMIN DECREASED | 12 0.12 11.91 BLOOD ALBUMIN INCREASED | 2 0.02 11.93 BLOOD ALKALINE PHOSPHATASE | 1 0.01 11.94 BLOOD ALKALINE PHOSPHATASE ABNORMAL | 1 0.01 11.95 BLOOD ALKALINE PHOSPHATASE INCREASED | 28 0.28 12.23 BLOOD AMYLASE INCREASED | 6 0.06 12.29 BLOOD BETA-D-GLUCAN INCREASED | 1 0.01 12.30 BLOOD BICARBONATE DECREASED | 2 0.02 12.32 BLOOD BICARBONATE INCREASED | 1 0.01 12.33 BLOOD BILIRUBIN ABNORMAL | 1 0.01 12.34 BLOOD BILIRUBIN INCREASED | 16 0.16 12.50 BLOOD BILIRUBIN UNCONJUGATED INCREASED | 2 0.02 12.52 BLOOD BROMIDE DECREASED | 1 0.01 12.53 BLOOD CALCIUM DECREASED | 10 0.10 12.63 BLOOD CALCIUM INCREASED | 2 0.02 12.65 BLOOD CHLORIDE DECREASED | 6 0.06 12.71 BLOOD CHOLESTEROL DECREASED | 1 0.01 12.72 BLOOD CHOLESTEROL INCREASED | 12 0.12 12.84 BLOOD CORTICOTROPHIN DECREASED | 2 0.02 12.86 BLOOD CORTISOL DECREASED | 2 0.02 12.88 BLOOD CREATINE INCREASED | 4 0.04 12.92 BLOOD CREATINE PHOSPHOKINASE INCREASED | 24 0.24 13.16 BLOOD CREATININE DECREASED | 1 0.01 13.17 BLOOD CREATININE INCREASED | 38 0.38 13.55 BLOOD CULTURE POSITIVE | 3 0.03 13.58 BLOOD DISORDER | 3 0.03 13.61 BLOOD ELECTROLYTES ABNORMAL | 1 0.01 13.62 BLOOD GASES ABNORMAL | 1 0.01 13.63 BLOOD GLUCOSE DECREASED | 7 0.07 13.70 BLOOD GLUCOSE FLUCTUATION | 1 0.01 13.71 BLOOD GLUCOSE INCREASED | 28 0.28 13.99 BLOOD HUMAN CHORIONIC GONADOTROPIN IN.. | 1 0.01 14.00 BLOOD IMMUNOGLOBULIN E INCREASED | 1 0.01 14.01 BLOOD IMMUNOGLOBULIN M INCREASED | 1 0.01 14.02 BLOOD LACTATE DEHYDROGENASE INCREASED | 16 0.16 14.18 BLOOD LACTIC ACID INCREASED | 2 0.02 14.20 BLOOD MAGNESIUM INCREASED | 1 0.01 14.21 BLOOD OSMOLARITY INCREASED | 1 0.01 14.22 BLOOD PH DECREASED | 2 0.02 14.24 BLOOD PHOSPHORUS DECREASED | 3 0.03 14.27 BLOOD PHOSPHORUS INCREASED | 1 0.01 14.28 BLOOD POTASSIUM DECREASED | 17 0.17 14.45 BLOOD POTASSIUM INCREASED | 6 0.06 14.51 BLOOD PRESSURE DECREASED | 23 0.23 14.74 BLOOD PRESSURE DIASTOLIC INCREASED | 1 0.01 14.75 BLOOD PRESSURE FLUCTUATION | 1 0.01 14.76 BLOOD PRESSURE IMMEASURABLE | 1 0.01 14.77 BLOOD PRESSURE INADEQUATELY CONTROLLED | 2 0.02 14.79 BLOOD PRESSURE INCREASED | 21 0.21 15.00 BLOOD PRESSURE ORTHOSTATIC ABNORMAL | 1 0.01 15.01 BLOOD PRESSURE SYSTOLIC DECREASED | 3 0.03 15.04 BLOOD PRESSURE SYSTOLIC INCREASED | 5 0.05 15.09 BLOOD PROLACTIN INCREASED | 2 0.02 15.11 BLOOD SODIUM DECREASED | 10 0.10 15.21 BLOOD SODIUM INCREASED | 1 0.01 15.22 BLOOD THYROID STIMULATING HORMONE DEC.. | 1 0.01 15.23 BLOOD TRIGLYCERIDES INCREASED | 8 0.08 15.31 BLOOD UREA ABNORMAL | 1 0.01 15.32 BLOOD UREA DECREASED | 2 0.02 15.34 BLOOD UREA INCREASED | 25 0.25 15.59 BLOOD URIC ACID DECREASED | 1 0.01 15.60 BLOOD URIC ACID INCREASED | 2 0.02 15.62 BLOOD URINE PRESENT | 3 0.03 15.65 BLUE TOE SYNDROME | 1 0.01 15.66 BODY TEMPERATURE DECREASED | 2 0.02 15.68 BODY TEMPERATURE INCREASED | 7 0.07 15.75 BONE DEBRIDEMENT | 6 0.06 15.81 BONE DENSITY DECREASED | 2 0.02 15.83 BONE DISORDER | 25 0.25 16.08 BONE FORMATION INCREASED | 1 0.01 16.09 BONE LESION | 1 0.01 16.10 BONE LESION EXCISION | 1 0.01 16.11 BONE MARROW DISORDER | 1 0.01 16.12 BONE MARROW FAILURE | 8 0.08 16.20 BONE MARROW MYELOGRAM ABNORMAL | 1 0.01 16.21 BONE NEOPLASM | 1 0.01 16.22 BONE PAIN | 4 0.04 16.26 BONE SARCOMA | 2 0.02 16.28 BONE TRIMMING | 3 0.03 16.31 BOVINE TUBERCULOSIS | 1 0.01 16.32 BOWEL MOVEMENT IRREGULARITY | 1 0.01 16.33 BOWEL SOUNDS ABNORMAL | 1 0.01 16.34 BRADYCARDIA | 13 0.13 16.47 BRADYCARDIA FOETAL | 1 0.01 16.48 BRADYCARDIA NEONATAL | 1 0.01 16.49 BRADYKINESIA | 1 0.01 16.50 BRAIN DEATH | 1 0.01 16.51 BRAIN NEOPLASM | 2 0.02 16.53 BRAIN OEDEMA | 4 0.04 16.57 BRAIN STEM SYNDROME | 1 0.01 16.58 BREAST CANCER | 10 0.10 16.68 BREAST CANCER FEMALE | 8 0.08 16.76 BREAST CANCER METASTATIC | 1 0.01 16.77 BREAST CANCER RECURRENT | 2 0.02 16.79 BREAST CANCER STAGE II | 1 0.01 16.80 BREAST CYST | 1 0.01 16.81 BREAST MASS | 2 0.02 16.83 BREAST OPERATION | 1 0.01 16.84 BREAST PAIN | 2 0.02 16.86 BREATH ODOUR | 1 0.01 16.87 BREATH SOUNDS ABNORMAL | 1 0.01 16.88 BREECH DELIVERY | 1 0.01 16.89 BRONCHIECTASIS | 1 0.01 16.90 BRONCHITIS | 8 0.08 16.98 BRONCHITIS ACUTE | 1 0.01 16.99 BRONCHOPNEUMONIA | 3 0.03 17.02 BRONCHOSCOPY | 1 0.01 17.03 BRONCHOSPASM | 2 0.02 17.05 BRUXISM | 2 0.02 17.07 BUDD-CHIARI SYNDROME | 1 0.01 17.08 BULIMIA NERVOSA | 1 0.01 17.09 BUNDLE BRANCH BLOCK | 1 0.01 17.10 BUNDLE BRANCH BLOCK LEFT | 1 0.01 17.11 BUNDLE BRANCH BLOCK RIGHT | 2 0.02 17.13 BURNING SENSATION | 4 0.04 17.17 BURNING SENSATION MUCOSAL | 1 0.01 17.18 BURNS THIRD DEGREE | 1 0.01 17.19 C-REACTIVE PROTEIN INCREASED | 16 0.16 17.35 CACHEXIA | 3 0.03 17.38 CAESAREAN SECTION | 21 0.21 17.59 CALCINOSIS | 4 0.04 17.63 CALCULUS BLADDER | 1 0.01 17.64 CALCULUS URETERIC | 1 0.01 17.65 CALCULUS URINARY | 1 0.01 17.66 CANDIDA SEPSIS | 2 0.02 17.68 CANDIDA SEROLOGY POSITIVE | 3 0.03 17.71 CANDIDIASIS | 4 0.04 17.75 CAPILLARY DISORDER | 4 0.04 17.79 CAPILLARY LEAK SYNDROME | 1 0.01 17.80 CARCINOMA IN SITU OF EYE | 1 0.01 17.81 CARDIAC ANEURYSM | 1 0.01 17.82 CARDIAC ARREST | 16 0.16 17.98 CARDIAC DISORDER | 6 0.06 18.04 CARDIAC FAILURE | 14 0.14 18.18 CARDIAC FAILURE ACUTE | 2 0.02 18.20 CARDIAC FAILURE CONGESTIVE | 20 0.20 18.40 CARDIAC FIBRILLATION | 1 0.01 18.41 CARDIAC HYPERTROPHY | 1 0.01 18.42 CARDIAC MURMUR | 2 0.02 18.44 CARDIAC PROCEDURE COMPLICATION | 1 0.01 18.45 CARDIO-RESPIRATORY ARREST | 11 0.11 18.56 CARDIO-RESPIRATORY DISTRESS | 1 0.01 18.57 CARDIOGENIC SHOCK | 1 0.01 18.58 CARDIOMEGALY | 5 0.05 18.63 CARDIOMYOPATHY | 6 0.06 18.69 CARDIOPULMONARY FAILURE | 1 0.01 18.70 CARDIOVASCULAR DISORDER | 1 0.01 18.71 CAROTID ARTERY DISEASE | 1 0.01 18.72 CAROTID ARTERY OCCLUSION | 1 0.01 18.73 CAROTID ARTERY STENOSIS | 4 0.04 18.77 CAROTIDYNIA | 1 0.01 18.78 CARPAL TUNNEL DECOMPRESSION | 1 0.01 18.79 CARPAL TUNNEL SYNDROME | 2 0.02 18.81 CASTLEMAN'S DISEASE | 1 0.01 18.82 CATARACT | 4 0.04 18.86 CATARACT OPERATION | 1 0.01 18.87 CATECHOLAMINES URINE INCREASED | 1 0.01 18.88 CATHETER PLACEMENT | 2 0.02 18.90 CATHETER RELATED INFECTION | 2 0.02 18.92 CATHETER SEPSIS | 1 0.01 18.93 CAUDA EQUINA SYNDROME | 1 0.01 18.94 CELL DEATH | 1 0.01 18.95 CELLULITIS | 14 0.14 19.09 CENTRAL LINE INFECTION | 1 0.01 19.10 CENTRAL NERVOUS SYSTEM LESION | 1 0.01 19.11 CEREBELLAR INFARCTION | 1 0.01 19.12 CEREBELLAR SYNDROME | 1 0.01 19.13 CEREBELLAR TUMOUR | 1 0.01 19.14 CEREBRAL ARTERITIS | 1 0.01 19.15 CEREBRAL ATROPHY | 4 0.04 19.19 CEREBRAL HAEMORRHAGE | 7 0.07 19.26 CEREBRAL INFARCTION | 4 0.04 19.30 CEREBRAL ISCHAEMIA | 7 0.07 19.37 CEREBRAL THROMBOSIS | 1 0.01 19.38 CEREBROVASCULAR ACCIDENT | 23 0.23 19.61 CERVICOBRACHIAL SYNDROME | 1 0.01 19.62 CERVIX DISORDER | 3 0.03 19.65 CHEILITIS | 1 0.01 19.66 CHEMOTHERAPY | 1 0.01 19.67 CHEST DISCOMFORT | 9 0.09 19.76 CHEST PAIN | 40 0.40 20.16 CHEST TUBE INSERTION | 2 0.02 20.18 CHEST X-RAY ABNORMAL | 2 0.02 20.20 CHILLS | 20 0.20 20.40 CHLAMYDIAL INFECTION | 1 0.01 20.41 CHOKING | 2 0.02 20.43 CHOLANGITIS SCLEROSING | 1 0.01 20.44 CHOLECYSTECTOMY | 2 0.02 20.46 CHOLECYSTITIS | 3 0.03 20.49 CHOLECYSTITIS ACUTE | 1 0.01 20.50 CHOLECYSTITIS CHRONIC | 2 0.02 20.52 CHOLEDOCHOENTEROSTOMY | 1 0.01 20.53 CHOLELITHIASIS | 8 0.08 20.61 CHOLESTASIS | 6 0.06 20.67 CHONDROCALCINOSIS | 1 0.01 20.68 CHORIOAMNIONITIS | 2 0.02 20.70 CHROMATURIA | 7 0.07 20.77 CHRONIC FATIGUE SYNDROME | 3 0.03 20.80 CHRONIC HEPATITIS | 1 0.01 20.81 CHRONIC LYMPHOCYTIC LEUKAEMIA | 2 0.02 20.83 CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 9 0.09 20.92 CIRCULATORY COLLAPSE | 8 0.08 21.00 CIRCUMSTANCE OR INFORMATION CAPABLE O.. | 2 0.02 21.02 CLEFT LIP | 1 0.01 21.03 CLOSTRIDIAL INFECTION | 2 0.02 21.05 CLOSTRIDIUM COLITIS | 1 0.01 21.06 CLOSTRIDIUM DIFFICILE COLITIS | 1 0.01 21.07 COAGULATION FACTOR DECREASED | 1 0.01 21.08 COAGULOPATHY | 2 0.02 21.10 COELIAC DISEASE | 1 0.01 21.11 COGNITIVE DISORDER | 7 0.07 21.18 COLD SWEAT | 1 0.01 21.19 COLD TYPE HAEMOLYTIC ANAEMIA | 1 0.01 21.20 COLITIS | 34 0.34 21.54 COLITIS EROSIVE | 1 0.01 21.55 COLITIS ISCHAEMIC | 1 0.01 21.56 COLITIS ULCERATIVE | 30 0.30 21.86 COLON ADENOMA | 1 0.01 21.87 COLON CANCER | 2 0.02 21.89 COLONIC POLYP | 3 0.03 21.92 COLONOSCOPY | 1 0.01 21.93 COLORECTAL CANCER METASTATIC | 2 0.02 21.95 COLOSTOMY | 1 0.01 21.96 COLOUR BLINDNESS | 1 0.01 21.97 COMA | 15 0.15 22.12 COMMINUTED FRACTURE | 1 0.01 22.13 COMMUNICATION DISORDER | 1 0.01 22.14 COMPLEMENT FACTOR C3 DECREASED | 1 0.01 22.15 COMPLEMENT FACTOR C4 DECREASED | 1 0.01 22.16 COMPLETED SUICIDE | 13 0.13 22.29 COMPLEX PARTIAL SEIZURES | 1 0.01 22.30 COMPLEX REGIONAL PAIN SYNDROME | 1 0.01 22.31 COMPRESSION FRACTURE | 1 0.01 22.32 COMPUTERISED TOMOGRAM ABNORMAL | 1 0.01 22.33 CONCUSSION | 1 0.01 22.34 CONDITION AGGRAVATED | 23 0.23 22.57 CONDUCTION DISORDER | 2 0.02 22.59 CONFUSIONAL STATE | 30 0.30 22.89 CONGENITAL ANOMALY | 2 0.02 22.91 CONGENITAL AORTIC ANOMALY | 1 0.01 22.92 CONGENITAL CENTRAL NERVOUS SYSTEM ANO.. | 1 0.01 22.93 CONGENITAL HYDRONEPHROSIS | 1 0.01 22.94 CONGENITAL TRICUSPID VALVE ATRESIA | 2 0.02 22.96 CONJUNCTIVAL HAEMORRHAGE | 2 0.02 22.98 CONJUNCTIVAL SCAR | 1 0.01 22.99 CONJUNCTIVITIS | 7 0.07 23.06 CONJUNCTIVITIS ALLERGIC | 1 0.01 23.07 CONSCIOUSNESS FLUCTUATING | 1 0.01 23.08 CONSTIPATION | 28 0.28 23.36 CONTRACTED BLADDER | 2 0.02 23.38 CONTUSION | 11 0.11 23.49 CONVALESCENT | 1 0.01 23.50 CONVERSION DISORDER | 1 0.01 23.51 CONVULSION | 45 0.45 23.96 CONVULSION NEONATAL | 1 0.01 23.97 COORDINATION ABNORMAL | 7 0.07 24.04 COPROLALIA | 1 0.01 24.05 CORNEAL OPACITY | 1 0.01 24.06 CORONARY ARTERY DISEASE | 10 0.10 24.16 CORONARY ARTERY OCCLUSION | 1 0.01 24.17 CORONARY ARTERY STENOSIS | 1 0.01 24.18 CORONARY ARTERY THROMBOSIS | 3 0.03 24.21 COSTOCHONDRITIS | 1 0.01 24.22 COUGH | 21 0.21 24.43 COXSACKIE VIRAL INFECTION | 1 0.01 24.44 CRANIAL SUTURES WIDENING | 1 0.01 24.45 CREATINE PHOSPHOKINASE DECREASED | 1 0.01 24.46 CREATININE RENAL CLEARANCE DECREASED | 4 0.04 24.50 CREATININE RENAL CLEARANCE INCREASED | 1 0.01 24.51 CREATININE URINE DECREASED | 2 0.02 24.53 CREATININE URINE INCREASED | 1 0.01 24.54 CREPITATIONS | 1 0.01 24.55 CROHN'S DISEASE | 17 0.17 24.72 CROSS SENSITIVITY REACTION | 1 0.01 24.73 CRUSH INJURY | 1 0.01 24.74 CRYING | 13 0.13 24.87 CSF PROTEIN INCREASED | 1 0.01 24.88 CSF WHITE BLOOD CELL COUNT POSITIVE | 1 0.01 24.89 CULTURE STOOL POSITIVE | 1 0.01 24.90 CULTURE URINE POSITIVE | 1 0.01 24.91 CULTURE WOUND POSITIVE | 1 0.01 24.92 CUSHING'S SYNDROME | 5 0.05 24.97 CUSHINGOID | 4 0.04 25.01 CUTANEOUS TUBERCULOSIS | 1 0.01 25.02 CUTANEOUS VASCULITIS | 1 0.01 25.03 CYANOSIS | 10 0.10 25.13 CYANOSIS NEONATAL | 1 0.01 25.14 CYST | 2 0.02 25.16 CYSTITIS | 6 0.06 25.22 CYSTITIS HAEMORRHAGIC | 2 0.02 25.24 CYSTITIS INTERSTITIAL | 1 0.01 25.25 CYSTITIS NONINFECTIVE | 1 0.01 25.26 CYTOLYTIC HEPATITIS | 4 0.04 25.30 CYTOMEGALOVIRUS INFECTION | 3 0.03 25.33 DEAFNESS | 3 0.03 25.36 DEAFNESS UNILATERAL | 2 0.02 25.38 DEATH | 57 0.57 25.95 DEATH NEONATAL | 3 0.03 25.98 DECOMPRESSION SICKNESS | 1 0.01 25.99 DECREASED ACTIVITY | 3 0.03 26.02 DECREASED APPETITE | 9 0.09 26.11 DECREASED INTEREST | 2 0.02 26.13 DECUBITUS ULCER | 2 0.02 26.15 DEEP VEIN THROMBOSIS | 13 0.13 26.28 DEFORMITY | 1 0.01 26.29 DEHYDRATION | 46 0.46 26.75 DELAYED FONTANELLE CLOSURE | 1 0.01 26.76 DELAYED RECOVERY FROM ANAESTHESIA | 1 0.01 26.77 DELIRIUM | 16 0.16 26.93 DELIRIUM FEBRILE | 1 0.01 26.94 DELIRIUM TREMENS | 1 0.01 26.95 DELUSION | 8 0.08 27.03 DELUSIONAL DISORDER, PERSECUTORY TYPE | 1 0.01 27.04 DEMENTIA | 6 0.06 27.10 DEMENTIA ALZHEIMER'S TYPE | 2 0.02 27.12 DENTAL CARIES | 1 0.01 27.13 DENTAL OPERATION | 1 0.01 27.14 DENTAL TREATMENT | 4 0.04 27.18 DENTURE WEARER | 1 0.01 27.19 DEPENDENCE | 5 0.05 27.24 DEPERSONALISATION | 1 0.01 27.25 DEPRESSED LEVEL OF CONSCIOUSNESS | 27 0.27 27.52 DEPRESSED MOOD | 2 0.02 27.54 DEPRESSION | 62 0.62 28.16 DEPRESSIVE SYMPTOM | 1 0.01 28.17 DEREALISATION | 1 0.01 28.18 DERMAL CYST | 2 0.02 28.20 DERMATITIS | 4 0.04 28.24 DERMATITIS ACNEIFORM | 1 0.01 28.25 DERMATITIS ALLERGIC | 2 0.02 28.27 DERMATITIS BULLOUS | 3 0.03 28.30 DERMATITIS EXFOLIATIVE | 3 0.03 28.33 DERMATOMYOSITIS | 1 0.01 28.34 DEVELOPMENTAL DELAY | 2 0.02 28.36 DEVICE FAILURE | 4 0.04 28.40 DEVICE MALFUNCTION | 1 0.01 28.41 DEVICE RELATED INFECTION | 2 0.02 28.43 DIABETES INSIPIDUS | 1 0.01 28.44 DIABETES MELLITUS | 16 0.16 28.60 DIABETES MELLITUS INADEQUATE CONTROL | 5 0.05 28.65 DIABETES MELLITUS INSULIN-DEPENDENT | 4 0.04 28.69 DIABETES MELLITUS NON-INSULIN-DEPENDENT | 5 0.05 28.74 DIABETIC COMA | 1 0.01 28.75 DIABETIC COMPLICATION | 1 0.01 28.76 DIABETIC FOOT | 1 0.01 28.77 DIABETIC HYPERGLYCAEMIC COMA | 1 0.01 28.78 DIABETIC KETOACIDOSIS | 3 0.03 28.81 DIABETIC NEPHROPATHY | 3 0.03 28.84 DIABETIC NEUROPATHY | 1 0.01 28.85 DIABETIC RETINOPATHY | 8 0.08 28.93 DIALYSIS | 6 0.06 28.99 DIAPHRAGMATIC DISORDER | 1 0.01 29.00 DIARRHOEA | 90 0.90 29.90 DIARRHOEA HAEMORRHAGIC | 2 0.02 29.92 DIFFUSE LARGE B-CELL LYMPHOMA | 3 0.03 29.95 DILATATION ATRIAL | 1 0.01 29.96 DILATATION VENTRICULAR | 1 0.01 29.97 DIPLOPIA | 4 0.04 30.01 DISABILITY | 1 0.01 30.02 DISCOMFORT | 3 0.03 30.05 DISEASE PROGRESSION | 8 0.08 30.13 DISEASE RECURRENCE | 8 0.08 30.21 DISORIENTATION | 15 0.15 30.36 DISSEMINATED INTRAVASCULAR COAGULATION | 9 0.09 30.45 DISSEMINATED TUBERCULOSIS | 2 0.02 30.47 DISSOCIATION | 3 0.03 30.50 DISTURBANCE IN ATTENTION | 21 0.21 30.71 DISTURBANCE IN SOCIAL BEHAVIOUR | 1 0.01 30.72 DIVERTICULAR PERFORATION | 1 0.01 30.73 DIVERTICULITIS | 7 0.07 30.80 DIVERTICULUM | 3 0.03 30.83 DIVERTICULUM INTESTINAL | 1 0.01 30.84 DIVERTICULUM INTESTINAL HAEMORRHAGIC | 1 0.01 30.85 DIZZINESS | 67 0.67 31.52 DIZZINESS POSTURAL | 1 0.01 31.53 DRESSLER'S SYNDROME | 1 0.01 31.54 DROWNING | 2 0.02 31.56 DRUG ABUSER | 8 0.08 31.64 DRUG ADMINISTRATION ERROR | 8 0.08 31.72 DRUG DEPENDENCE | 7 0.07 31.79 DRUG DISPENSING ERROR | 3 0.03 31.82 DRUG DOSE OMISSION | 5 0.05 31.87 DRUG EFFECT DECREASED | 8 0.08 31.95 DRUG EFFECT INCREASED | 1 0.01 31.96 DRUG EFFECT PROLONGED | 1 0.01 31.97 DRUG ERUPTION | 7 0.07 32.04 DRUG EXPOSURE BEFORE PREGNANCY | 12 0.12 32.16 DRUG EXPOSURE DURING PREGNANCY | 81 0.81 32.97 DRUG EXPOSURE VIA BREAST MILK | 5 0.05 33.02 DRUG HYPERSENSITIVITY | 13 0.13 33.15 DRUG INEFFECTIVE | 52 0.52 33.67 DRUG INTERACTION | 39 0.39 34.06 DRUG INTOLERANCE | 5 0.05 34.11 DRUG LEVEL BELOW THERAPEUTIC | 1 0.01 34.12 DRUG LEVEL DECREASED | 1 0.01 34.13 DRUG LEVEL FLUCTUATING | 3 0.03 34.16 DRUG LEVEL INCREASED | 3 0.03 34.19 DRUG PRESCRIBING ERROR | 1 0.01 34.20 DRUG RASH WITH EOSINOPHILIA AND SYSTE.. | 3 0.03 34.23 DRUG RESISTANCE | 2 0.02 34.25 DRUG SPECIFIC ANTIBODY ABSENT | 1 0.01 34.26 DRUG TOLERANCE | 1 0.01 34.27 DRUG TOXICITY | 11 0.11 34.38 DRUG WITHDRAWAL CONVULSIONS | 1 0.01 34.39 DRUG WITHDRAWAL SYNDROME | 32 0.32 34.71 DRUG WITHDRAWAL SYNDROME NEONATAL | 2 0.02 34.73 DRY EYE | 11 0.11 34.84 DRY MOUTH | 10 0.10 34.94 DRY SKIN | 18 0.18 35.12 DRY THROAT | 1 0.01 35.13 DUODENAL ULCER | 1 0.01 35.14 DUODENAL ULCER HAEMORRHAGE | 1 0.01 35.15 DUODENAL ULCER PERFORATION | 1 0.01 35.16 DUODENITIS | 2 0.02 35.18 DUPUYTREN'S CONTRACTURE | 2 0.02 35.20 DYSAESTHESIA PHARYNX | 2 0.02 35.22 DYSARTHRIA | 10 0.10 35.32 DYSGEUSIA | 9 0.09 35.41 DYSKINESIA | 7 0.07 35.48 DYSLALIA | 3 0.03 35.51 DYSLIPIDAEMIA | 1 0.01 35.52 DYSMENORRHOEA | 1 0.01 35.53 DYSMORPHISM | 1 0.01 35.54 DYSPEPSIA | 11 0.11 35.65 DYSPHAGIA | 19 0.19 35.84 DYSPHONIA | 4 0.04 35.88 DYSPNOEA | 72 0.72 36.60 DYSPNOEA EXERTIONAL | 3 0.03 36.63 DYSPNOEA PAROXYSMAL NOCTURNAL | 2 0.02 36.65 DYSSTASIA | 6 0.06 36.71 DYSTHYMIC DISORDER | 2 0.02 36.73 DYSTONIA | 2 0.02 36.75 DYSURIA | 6 0.06 36.81 EAR DISORDER | 1 0.01 36.82 EAR INFECTION | 3 0.03 36.85 EAR PAIN | 3 0.03 36.88 EATING DISORDER | 7 0.07 36.95 ECCHYMOSIS | 3 0.03 36.98 ECHOCARDIOGRAM ABNORMAL | 2 0.02 37.00 ECONOMIC PROBLEM | 1 0.01 37.01 ECZEMA | 1 0.01 37.02 EDUCATIONAL PROBLEM | 1 0.01 37.03 EJACULATION DISORDER | 1 0.01 37.04 ELECTROCARDIOGRAM ABNORMAL | 2 0.02 37.06 ELECTROCARDIOGRAM CHANGE | 1 0.01 37.07 ELECTROCARDIOGRAM P WAVE ABNORMAL | 1 0.01 37.08 ELECTROCARDIOGRAM QT CORRECTED INTERV.. | 3 0.03 37.11 ELECTROCARDIOGRAM QT PROLONGED | 5 0.05 37.16 ELECTROCARDIOGRAM ST SEGMENT ABNORMAL | 1 0.01 37.17 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION | 2 0.02 37.19 ELECTROCARDIOGRAM ST-T SEGMENT ABNORMAL | 1 0.01 37.20 ELECTROCARDIOGRAM T WAVE ABNORMAL | 2 0.02 37.22 ELECTROCARDIOGRAM T WAVE AMPLITUDE DE.. | 1 0.01 37.23 ELECTROENCEPHALOGRAM ABNORMAL | 2 0.02 37.25 ELECTROLYTE IMBALANCE | 4 0.04 37.29 ELECTROMECHANICAL DISSOCIATION | 1 0.01 37.30 EMBOLISM | 1 0.01 37.31 EMOTIONAL DISORDER | 1 0.01 37.32 EMOTIONAL DISTRESS | 9 0.09 37.41 EMPHYSEMA | 2 0.02 37.43 EMPYEMA | 1 0.01 37.44 ENCEPHALITIS | 2 0.02 37.46 ENCEPHALITIS HERPES | 1 0.01 37.47 ENCEPHALOPATHY | 5 0.05 37.52 ENCOPRESIS | 1 0.01 37.53 ENDOCARDITIS | 1 0.01 37.54 ENDOMETRIAL CANCER | 1 0.01 37.55 ENDOMETRIOSIS | 2 0.02 37.57 ENDOPHTHALMITIS | 2 0.02 37.59 ENDOSCOPIC RETROGRADE CHOLANGIOPANCRE.. | 1 0.01 37.60 ENDOSCOPY | 1 0.01 37.61 ENERGY INCREASED | 1 0.01 37.62 ENTERITIS | 2 0.02 37.64 ENTEROCOCCAL INFECTION | 1 0.01 37.65 ENTEROCOLITIS HAEMORRHAGIC | 3 0.03 37.68 ENURESIS | 1 0.01 37.69 EOSINOPHIL COUNT INCREASED | 3 0.03 37.72 EOSINOPHIL PERCENTAGE INCREASED | 1 0.01 37.73 EOSINOPHILIA | 9 0.09 37.82 EPIDEMIC PLEURODYNIA | 1 0.01 37.83 EPIDERMOLYSIS | 1 0.01 37.84 EPIGASTRIC DISCOMFORT | 1 0.01 37.85 EPILEPSY | 5 0.05 37.90 EPISCLERITIS | 1 0.01 37.91 EPISTAXIS | 12 0.12 38.03 EPITHELIOMA | 1 0.01 38.04 EPSTEIN-BARR VIRUS ANTIBODY POSITIVE | 1 0.01 38.05 EPSTEIN-BARR VIRUS INFECTION | 8 0.08 38.13 EPSTEIN-BARR VIRUS TEST POSITIVE | 1 0.01 38.14 ERUCTATION | 2 0.02 38.16 ERYSIPELAS | 4 0.04 38.20 ERYTHEMA | 18 0.18 38.38 ERYTHEMA MULTIFORME | 1 0.01 38.39 ERYTHEMA NODOSUM | 1 0.01 38.40 ESCHERICHIA INFECTION | 2 0.02 38.42 ESCHERICHIA URINARY TRACT INFECTION | 2 0.02 38.44 EUPHORIC MOOD | 1 0.01 38.45 EXCESSIVE EYE BLINKING | 1 0.01 38.46 EXOSTOSIS | 1 0.01 38.47 EXPOSURE TO TOXIC AGENT | 1 0.01 38.48 EXPRESSIVE LANGUAGE DISORDER | 1 0.01 38.49 EXTRADURAL HAEMATOMA | 1 0.01 38.50 EXTRAPYRAMIDAL DISORDER | 5 0.05 38.55 EXTRASYSTOLES | 4 0.04 38.59 EXTRAVASATION | 2 0.02 38.61 EYE DISCHARGE | 1 0.01 38.62 EYE DISORDER | 7 0.07 38.69 EYE HAEMORRHAGE | 4 0.04 38.73 EYE INFECTION | 3 0.03 38.76 EYE INFLAMMATION | 2 0.02 38.78 EYE INJURY | 1 0.01 38.79 EYE IRRITATION | 1 0.01 38.80 EYE PAIN | 7 0.07 38.87 EYE PRURITUS | 1 0.01 38.88 EYE SWELLING | 1 0.01 38.89 EYELID OEDEMA | 3 0.03 38.92 FACE OEDEMA | 8 0.08 39.00 FACIAL BONES FRACTURE | 2 0.02 39.02 FACIAL PAIN | 3 0.03 39.05 FACIAL PALSY | 6 0.06 39.11 FACIAL PARESIS | 1 0.01 39.12 FAECAL INCONTINENCE | 1 0.01 39.13 FAECALOMA | 2 0.02 39.15 FAECES DISCOLOURED | 4 0.04 39.19 FAILURE OF IMPLANT | 1 0.01 39.20 FALL | 49 0.49 39.69 FALSE POSITIVE LABORATORY RESULT | 1 0.01 39.70 FANCONI SYNDROME | 1 0.01 39.71 FANCONI SYNDROME ACQUIRED | 1 0.01 39.72 FASCIITIS | 1 0.01 39.73 FAT REDISTRIBUTION | 1 0.01 39.74 FAT TISSUE INCREASED | 1 0.01 39.75 FATIGUE | 60 0.60 40.35 FEAR | 3 0.03 40.38 FEBRILE BONE MARROW APLASIA | 1 0.01 40.39 FEBRILE CONVULSION | 1 0.01 40.40 FEBRILE INFECTION | 1 0.01 40.41 FEBRILE NEUTROPENIA | 7 0.07 40.48 FEEDING DISORDER NEONATAL | 3 0.03 40.51 FEELING ABNORMAL | 17 0.17 40.68 FEELING COLD | 4 0.04 40.72 FEELING DRUNK | 1 0.01 40.73 FEELING GUILTY | 2 0.02 40.75 FEELING HOT | 3 0.03 40.78 FEELING HOT AND COLD | 2 0.02 40.80 FEELING JITTERY | 2 0.02 40.82 FEELING OF DESPAIR | 3 0.03 40.85 FEELINGS OF WORTHLESSNESS | 1 0.01 40.86 FEMALE GENITAL TRACT FISTULA | 1 0.01 40.87 FEMORAL NECK FRACTURE | 4 0.04 40.91 FEMUR FRACTURE | 2 0.02 40.93 FIBRIN D DIMER INCREASED | 2 0.02 40.95 FIBROADENOMA | 1 0.01 40.96 FIBROCYSTIC BREAST DISEASE | 1 0.01 40.97 FIBROMYALGIA | 3 0.03 41.00 FIBROSARCOMA | 1 0.01 41.01 FIBROSIS | 3 0.03 41.04 FIBROUS HISTIOCYTOMA | 1 0.01 41.05 FIBULA FRACTURE | 2 0.02 41.07 FISTULA | 7 0.07 41.14 FISTULA REPAIR | 1 0.01 41.15 FLANK PAIN | 5 0.05 41.20 FLATULENCE | 11 0.11 41.31 FLIGHT OF IDEAS | 1 0.01 41.32 FLUID INTAKE REDUCED | 2 0.02 41.34 FLUID RETENTION | 1 0.01 41.35 FLUSHING | 11 0.11 41.46 FOAMING AT MOUTH | 1 0.01 41.47 FOCAL GLOMERULOSCLEROSIS | 2 0.02 41.49 FOETAL CARDIAC DISORDER | 1 0.01 41.50 FOETAL DISORDER | 3 0.03 41.53 FOETAL DISTRESS SYNDROME | 5 0.05 41.58 FOETAL GROWTH RETARDATION | 4 0.04 41.62 FOETAL MALFORMATION | 1 0.01 41.63 FOETAL MOVEMENTS DECREASED | 1 0.01 41.64 FOLATE DEFICIENCY | 1 0.01 41.65 FOLLICULITIS | 1 0.01 41.66 FOOD ALLERGY | 1 0.01 41.67 FOOD INTOLERANCE | 1 0.01 41.68 FOOT DEFORMITY | 1 0.01 41.69 FOOT FRACTURE | 2 0.02 41.71 FOREIGN BODY TRAUMA | 4 0.04 41.75 FORMICATION | 1 0.01 41.76 FRACTURE | 3 0.03 41.79 FRACTURE DISPLACEMENT | 1 0.01 41.80 FREQUENT BOWEL MOVEMENTS | 1 0.01 41.81 FRUSTRATION | 1 0.01 41.82 FULL BLOOD COUNT ABNORMAL | 1 0.01 41.83 FULL BLOOD COUNT DECREASED | 1 0.01 41.84 FUMBLING | 1 0.01 41.85 FUNGAL INFECTION | 6 0.06 41.91 FUNGAL SKIN INFECTION | 1 0.01 41.92 FUNISITIS | 2 0.02 41.94 FURUNCLE | 1 0.01 41.95 FUSARIUM INFECTION | 1 0.01 41.96 GAIT DISTURBANCE | 23 0.23 42.19 GALACTORRHOEA | 2 0.02 42.21 GALLBLADDER DISORDER | 2 0.02 42.23 GALLBLADDER OPERATION | 1 0.01 42.24 GAMMA-GLUTAMYLTRANSFERASE ABNORMAL | 1 0.01 42.25 GAMMA-GLUTAMYLTRANSFERASE INCREASED | 24 0.24 42.49 GANGRENE | 1 0.01 42.50 GASTRECTOMY | 1 0.01 42.51 GASTRIC BYPASS | 1 0.01 42.52 GASTRIC CANCER | 4 0.04 42.56 GASTRIC DISORDER | 4 0.04 42.60 GASTRIC HAEMORRHAGE | 2 0.02 42.62 GASTRIC LAVAGE | 1 0.01 42.63 GASTRIC ULCER | 7 0.07 42.70 GASTRIC ULCER HAEMORRHAGE | 1 0.01 42.71 GASTRIC ULCER PERFORATION | 1 0.01 42.72 GASTRIC VARICES HAEMORRHAGE | 1 0.01 42.73 GASTRITIS | 12 0.12 42.85 GASTRITIS EROSIVE | 1 0.01 42.86 GASTRODUODENAL ULCER | 1 0.01 42.87 GASTROENTERITIS | 6 0.06 42.93 GASTROENTERITIS ROTAVIRUS | 1 0.01 42.94 GASTROINTESTINAL ANASTOMOTIC LEAK | 2 0.02 42.96 GASTROINTESTINAL DISORDER | 33 0.33 43.29 GASTROINTESTINAL FISTULA | 1 0.01 43.30 GASTROINTESTINAL HAEMORRHAGE | 14 0.14 43.44 GASTROINTESTINAL INFECTION | 4 0.04 43.48 GASTROINTESTINAL INFLAMMATION | 2 0.02 43.50 GASTROINTESTINAL INJURY | 34 0.34 43.84 GASTROINTESTINAL MALFORMATION | 1 0.01 43.85 GASTROINTESTINAL MOTILITY DISORDER | 1 0.01 43.86 GASTROINTESTINAL NECROSIS | 1 0.01 43.87 GASTROINTESTINAL OEDEMA | 1 0.01 43.88 GASTROINTESTINAL PAIN | 3 0.03 43.91 GASTROINTESTINAL STOMA COMPLICATION | 1 0.01 43.92 GASTROINTESTINAL TUBE INSERTION | 1 0.01 43.93 GASTROINTESTINAL ULCER HAEMORRHAGE | 2 0.02 43.95 GASTROOESOPHAGEAL REFLUX DISEASE | 16 0.16 44.11 GAZE PALSY | 1 0.01 44.12 GENERAL PHYSICAL CONDITION ABNORMAL | 2 0.02 44.14 GENERAL PHYSICAL HEALTH DETERIORATION | 22 0.22 44.36 GENERALISED ERYTHEMA | 1 0.01 44.37 GENERALISED OEDEMA | 3 0.03 44.40 GENITAL BURNING SENSATION | 1 0.01 44.41 GESTATIONAL DIABETES | 2 0.02 44.43 GILBERT'S SYNDROME | 1 0.01 44.44 GINGIVAL BLEEDING | 3 0.03 44.47 GINGIVAL DISORDER | 1 0.01 44.48 GINGIVAL HYPERPLASIA | 1 0.01 44.49 GINGIVAL RECESSION | 2 0.02 44.51 GINGIVAL SWELLING | 3 0.03 44.54 GINGIVAL ULCERATION | 1 0.01 44.55 GINGIVITIS | 2 0.02 44.57 GLAUCOMA | 5 0.05 44.62 GLOBULINS INCREASED | 1 0.01 44.63 GLOMERULONEPHRITIS | 1 0.01 44.64 GLOMERULOSCLEROSIS | 1 0.01 44.65 GLOSSODYNIA | 1 0.01 44.66 GLUCOSE TOLERANCE IMPAIRED | 2 0.02 44.68 GLYCOSURIA | 1 0.01 44.69 GLYCOSYLATED HAEMOGLOBIN INCREASED | 6 0.06 44.75 GOITRE | 4 0.04 44.79 GRAFT COMPLICATION | 1 0.01 44.80 GRAFT DYSFUNCTION | 1 0.01 44.81 GRAFT VERSUS HOST DISEASE | 1 0.01 44.82 GRAM STAIN POSITIVE | 1 0.01 44.83 GRAND MAL CONVULSION | 10 0.10 44.93 GRANULOCYTOPENIA | 2 0.02 44.95 GRANULOMA | 5 0.05 45.00 GROIN PAIN | 4 0.04 45.04 GUILLAIN-BARRE SYNDROME | 1 0.01 45.05 GUN SHOT WOUND | 1 0.01 45.06 GYNAECOMASTIA | 1 0.01 45.07 HAEMANGIOMA | 2 0.02 45.09 HAEMANGIOMA OF LIVER | 1 0.01 45.10 HAEMANGIOMA OF SKIN | 1 0.01 45.11 HAEMANGIOMA REMOVAL | 1 0.01 45.12 HAEMATEMESIS | 9 0.09 45.21 HAEMATOCHEZIA | 14 0.14 45.35 HAEMATOCRIT DECREASED | 13 0.13 45.48 HAEMATOCRIT INCREASED | 1 0.01 45.49 HAEMATOMA | 8 0.08 45.57 HAEMATOMA EVACUATION | 1 0.01 45.58 HAEMATOTOXICITY | 1 0.01 45.59 HAEMATURIA | 10 0.10 45.69 HAEMODIALYSIS | 7 0.07 45.76 HAEMODYNAMIC INSTABILITY | 1 0.01 45.77 HAEMOGLOBIN DECREASED | 43 0.43 46.20 HAEMOGLOBIN INCREASED | 1 0.01 46.21 HAEMOLYSIS | 1 0.01 46.22 HAEMOLYTIC ANAEMIA | 2 0.02 46.24 HAEMOLYTIC URAEMIC SYNDROME | 3 0.03 46.27 HAEMOPHILIA | 1 0.01 46.28 HAEMOPTYSIS | 3 0.03 46.31 HAEMORRHAGE | 13 0.13 46.44 HAEMORRHAGE INTRACRANIAL | 2 0.02 46.46 HAEMORRHAGE SUBCUTANEOUS | 1 0.01 46.47 HAEMORRHAGE URINARY TRACT | 1 0.01 46.48 HAEMORRHAGIC CYST | 1 0.01 46.49 HAEMORRHAGIC DIATHESIS | 3 0.03 46.52 HAEMORRHAGIC DISORDER | 1 0.01 46.53 HAEMORRHAGIC STROKE | 1 0.01 46.54 HAEMORRHOIDAL HAEMORRHAGE | 1 0.01 46.55 HAEMORRHOIDS | 12 0.12 46.67 HAIR TEXTURE ABNORMAL | 3 0.03 46.70 HALLUCINATION | 22 0.22 46.92 HALLUCINATION, AUDITORY | 3 0.03 46.95 HALLUCINATIONS, MIXED | 1 0.01 46.96 HAND FRACTURE | 3 0.03 46.99 HBV DNA INCREASED | 1 0.01 47.00 HEAD INJURY | 5 0.05 47.05 HEADACHE | 66 0.66 47.71 HEARING IMPAIRED | 2 0.02 47.73 HEART DISEASE CONGENITAL | 4 0.04 47.77 HEART RATE DECREASED | 2 0.02 47.79 HEART RATE INCREASED | 13 0.13 47.92 HEART RATE IRREGULAR | 9 0.09 48.01 HELICOBACTER INFECTION | 2 0.02 48.03 HELICOBACTER PYLORI IDENTIFICATION TE.. | 1 0.01 48.04 HEMIPARESIS | 4 0.04 48.08 HEMIPLEGIA | 5 0.05 48.13 HEPARIN-INDUCED THROMBOCYTOPENIA | 2 0.02 48.15 HEPATIC CIRRHOSIS | 5 0.05 48.20 HEPATIC CONGESTION | 2 0.02 48.22 HEPATIC CYST | 1 0.01 48.23 HEPATIC ENCEPHALOPATHY | 1 0.01 48.24 HEPATIC ENZYME ABNORMAL | 1 0.01 48.25 HEPATIC ENZYME INCREASED | 19 0.19 48.44 HEPATIC FAILURE | 18 0.18 48.62 HEPATIC FIBROSIS | 4 0.04 48.66 HEPATIC FUNCTION ABNORMAL | 24 0.24 48.90 HEPATIC LESION | 2 0.02 48.92 HEPATIC NECROSIS | 1 0.01 48.93 HEPATIC NEOPLASM MALIGNANT | 3 0.03 48.96 HEPATIC PAIN | 1 0.01 48.97 HEPATIC STEATOSIS | 7 0.07 49.04 HEPATIC VEIN OCCLUSION | 1 0.01 49.05 HEPATITIS | 15 0.15 49.20 HEPATITIS A ANTIBODY POSITIVE | 1 0.01 49.21 HEPATITIS ACUTE | 2 0.02 49.23 HEPATITIS B | 3 0.03 49.26 HEPATITIS B E ANTIGEN | 1 0.01 49.27 HEPATITIS C | 2 0.02 49.29 HEPATITIS CHOLESTATIC | 3 0.03 49.32 HEPATITIS FULMINANT | 5 0.05 49.37 HEPATITIS TOXIC | 1 0.01 49.38 HEPATITIS VIRAL | 1 0.01 49.39 HEPATOBLASTOMA | 1 0.01 49.40 HEPATOCELLULAR DAMAGE | 10 0.10 49.50 HEPATOMEGALY | 8 0.08 49.58 HEPATORENAL SYNDROME | 1 0.01 49.59 HEPATOSPLENOMEGALY | 1 0.01 49.60 HEPATOTOXICITY | 4 0.04 49.64 HERNIA | 3 0.03 49.67 HERPES SIMPLEX | 3 0.03 49.70 HERPES VIRUS INFECTION | 1 0.01 49.71 HERPES ZOSTER | 7 0.07 49.78 HIATUS HERNIA | 2 0.02 49.80 HIGH ARCHED PALATE | 1 0.01 49.81 HIGH DENSITY LIPOPROTEIN DECREASED | 1 0.01 49.82 HIGH DENSITY LIPOPROTEIN INCREASED | 1 0.01 49.83 HILAR LYMPHADENOPATHY | 1 0.01 49.84 HIP ARTHROPLASTY | 4 0.04 49.88 HIP FRACTURE | 8 0.08 49.96 HISTIOCYTOSIS HAEMATOPHAGIC | 3 0.03 49.99 HODGKIN'S DISEASE | 4 0.04 50.03 HODGKIN'S DISEASE MIXED CELLULARITY S.. | 1 0.01 50.04 HODGKIN'S DISEASE NODULAR SCLEROSIS S.. | 1 0.01 50.05 HOMICIDAL IDEATION | 1 0.01 50.06 HOMICIDE | 1 0.01 50.07 HOMOCYSTINAEMIA | 1 0.01 50.08 HOSPITALISATION | 2 0.02 50.10 HOT FLUSH | 4 0.04 50.14 HUMERUS FRACTURE | 1 0.01 50.15 HUNGER | 2 0.02 50.17 HYDROCEPHALUS | 2 0.02 50.19 HYDRONEPHROSIS | 2 0.02 50.21 HYDROPS FOETALIS | 1 0.01 50.22 HYPERACUSIS | 4 0.04 50.26 HYPERAEMIA | 1 0.01 50.27 HYPERALBUMINAEMIA | 1 0.01 50.28 HYPERBARIC OXYGEN THERAPY | 1 0.01 50.29 HYPERBILIRUBINAEMIA | 3 0.03 50.32 HYPERCALCAEMIA | 4 0.04 50.36 HYPERCAPNIA | 1 0.01 50.37 HYPERCHLORAEMIA | 1 0.01 50.38 HYPERCHOLESTEROLAEMIA | 2 0.02 50.40 HYPERCOAGULATION | 1 0.01 50.41 HYPERGAMMAGLOBULINAEMIA | 3 0.03 50.44 HYPERGLYCAEMIA | 8 0.08 50.52 HYPERHIDROSIS | 28 0.28 50.80 HYPERKALAEMIA | 6 0.06 50.86 HYPERKERATOSIS | 1 0.01 50.87 HYPERLACTACIDAEMIA | 1 0.01 50.88 HYPERLIPIDAEMIA | 5 0.05 50.93 HYPERPARATHYROIDISM PRIMARY | 1 0.01 50.94 HYPERPHAGIA | 1 0.01 50.95 HYPERPROLACTINAEMIA | 1 0.01 50.96 HYPERSENSITIVITY | 13 0.13 51.09 HYPERSOMNIA | 3 0.03 51.12 HYPERTENSION | 31 0.31 51.43 HYPERTENSIVE CRISIS | 6 0.06 51.49 HYPERTHERMIA MALIGNANT | 1 0.01 51.50 HYPERTHYROIDISM | 2 0.02 51.52 HYPERTONIA | 1 0.01 51.53 HYPERTONIC BLADDER | 1 0.01 51.54 HYPERTROPHIC CARDIOMYOPATHY | 1 0.01 51.55 HYPERURICAEMIA | 1 0.01 51.56 HYPERVENTILATION | 2 0.02 51.58 HYPOACUSIS | 1 0.01 51.59 HYPOAESTHESIA | 27 0.27 51.86 HYPOAESTHESIA ORAL | 2 0.02 51.88 HYPOALBUMINAEMIA | 5 0.05 51.93 HYPOCALCAEMIA | 8 0.08 52.01 HYPOCAPNIA | 3 0.03 52.04 HYPOCHLORAEMIA | 1 0.01 52.05 HYPOGEUSIA | 1 0.01 52.06 HYPOGLYCAEMIA | 22 0.22 52.28 HYPOGLYCAEMIA NEONATAL | 1 0.01 52.29 HYPOGLYCAEMIC COMA | 5 0.05 52.34 HYPOGLYCAEMIC SEIZURE | 1 0.01 52.35 HYPOKALAEMIA | 18 0.18 52.53 HYPOKINESIA | 2 0.02 52.55 HYPOMAGNESAEMIA | 4 0.04 52.59 HYPONATRAEMIA | 19 0.19 52.78 HYPOPHOSPHATAEMIA | 1 0.01 52.79 HYPOPROTEINAEMIA | 1 0.01 52.80 HYPOSMIA | 1 0.01 52.81 HYPOTENSION | 36 0.36 53.17 HYPOTHERMIA | 4 0.04 53.21 HYPOTHYROIDISM | 5 0.05 53.26 HYPOTONIA | 6 0.06 53.32 HYPOTONIA NEONATAL | 1 0.01 53.33 HYPOVOLAEMIA | 3 0.03 53.36 HYPOXIA | 15 0.15 53.51 HYSTERECTOMY | 2 0.02 53.53 ILEAL STENOSIS | 1 0.01 53.54 ILEITIS | 2 0.02 53.56 ILEUS | 7 0.07 53.63 ILEUS PARALYTIC | 2 0.02 53.65 ILL-DEFINED DISORDER | 9 0.09 53.74 ILLUSION | 2 0.02 53.76 IMMATURE RESPIRATORY SYSTEM | 2 0.02 53.78 IMMOBILE | 2 0.02 53.80 IMMUNE RECONSTITUTION SYNDROME | 2 0.02 53.82 IMMUNE SYSTEM DISORDER | 1 0.01 53.83 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED | 1 0.01 53.84 IMMUNOSUPPRESSION | 1 0.01 53.85 IMPAIRED GASTRIC EMPTYING | 2 0.02 53.87 IMPAIRED HEALING | 21 0.21 54.08 IMPAIRED WORK ABILITY | 4 0.04 54.12 IMPINGEMENT SYNDROME | 1 0.01 54.13 IMPULSE-CONTROL DISORDER | 2 0.02 54.15 IMPULSIVE BEHAVIOUR | 3 0.03 54.18 INAPPROPRIATE ANTIDIURETIC HORMONE SE.. | 2 0.02 54.20 INAPPROPRIATE SCHEDULE OF DRUG ADMINI.. | 2 0.02 54.22 INCISION SITE COMPLICATION | 1 0.01 54.23 INCISIONAL DRAINAGE | 1 0.01 54.24 INCISIONAL HERNIA REPAIR | 1 0.01 54.25 INCOHERENT | 2 0.02 54.27 INCONTINENCE | 1 0.01 54.28 INCORRECT DOSE ADMINISTERED | 5 0.05 54.33 INCORRECT ROUTE OF DRUG ADMINISTRATION | 4 0.04 54.37 INCREASED APPETITE | 1 0.01 54.38 INCREASED BRONCHIAL SECRETION | 3 0.03 54.41 INFARCTION | 3 0.03 54.44 INFECTION | 18 0.18 54.62 INFECTIOUS MONONUCLEOSIS | 1 0.01 54.63 INFERTILITY | 1 0.01 54.64 INFLAMMATION | 13 0.13 54.77 INFLAMMATORY BOWEL DISEASE | 36 0.36 55.13 INFLUENZA | 5 0.05 55.18 INFLUENZA LIKE ILLNESS | 4 0.04 55.22 INFUSION RELATED REACTION | 16 0.16 55.38 INGUINAL HERNIA | 1 0.01 55.39 INGUINAL HERNIA REPAIR | 1 0.01 55.40 INJECTION SITE BRUISING | 3 0.03 55.43 INJECTION SITE DISCOLOURATION | 2 0.02 55.45 INJECTION SITE ERYTHEMA | 4 0.04 55.49 INJECTION SITE HAEMATOMA | 1 0.01 55.50 INJECTION SITE HAEMORRHAGE | 4 0.04 55.54 INJECTION SITE NECROSIS | 2 0.02 55.56 INJECTION SITE PAIN | 10 0.10 55.66 INJECTION SITE PHLEBITIS | 1 0.01 55.67 INJECTION SITE REACTION | 8 0.08 55.75 INJECTION SITE SWELLING | 1 0.01 55.76 INJECTION SITE VESICLES | 1 0.01 55.77 INJURY | 14 0.14 55.91 INNER EAR DISORDER | 1 0.01 55.92 INSOMNIA | 48 0.48 56.40 INSULIN RESISTANCE | 1 0.01 56.41 INTENTIONAL DRUG MISUSE | 6 0.06 56.47 INTENTIONAL OVERDOSE | 5 0.05 56.52 INTENTIONAL SELF-INJURY | 2 0.02 56.54 INTERMITTENT CLAUDICATION | 1 0.01 56.55 INTERNAL INJURY | 3 0.03 56.58 INTERNATIONAL NORMALISED RATIO ABNORMAL | 1 0.01 56.59 INTERNATIONAL NORMALISED RATIO FLUCTU.. | 2 0.02 56.61 INTERNATIONAL NORMALISED RATIO INCREA.. | 10 0.10 56.71 INTERSTITIAL LUNG DISEASE | 13 0.13 56.84 INTERVERTEBRAL DISC DEGENERATION | 1 0.01 56.85 INTERVERTEBRAL DISC PROTRUSION | 1 0.01 56.86 INTESTINAL HAEMORRHAGE | 24 0.24 57.10 INTESTINAL INFARCTION | 1 0.01 57.11 INTESTINAL ISCHAEMIA | 2 0.02 57.13 INTESTINAL OBSTRUCTION | 10 0.10 57.23 INTESTINAL RESECTION | 1 0.01 57.24 INTESTINAL ULCER | 1 0.01 57.25 INTESTINAL VILLI ATROPHY | 1 0.01 57.26 INTRA-UTERINE DEATH | 2 0.02 57.28 INTRACRANIAL ANEURYSM | 2 0.02 57.30 INTRACRANIAL HAEMATOMA | 1 0.01 57.31 INTRACRANIAL PRESSURE INCREASED | 2 0.02 57.33 INTRAOCULAR PRESSURE INCREASED | 2 0.02 57.35 INTRAUTERINE INFECTION | 1 0.01 57.36 INTUBATION | 4 0.04 57.40 INVESTIGATION ABNORMAL | 1 0.01 57.41 IRIS DISORDER | 1 0.01 57.42 IRITIS | 11 0.11 57.53 IRON DEFICIENCY ANAEMIA | 3 0.03 57.56 IRRITABILITY | 16 0.16 57.72 IRRITABLE BOWEL SYNDROME | 19 0.19 57.91 ISCHAEMIA | 2 0.02 57.93 ISCHAEMIC HEPATITIS | 2 0.02 57.95 ISCHAEMIC STROKE | 3 0.03 57.98 JAUNDICE | 13 0.13 58.11 JAUNDICE CHOLESTATIC | 2 0.02 58.13 JAUNDICE HEPATOCELLULAR | 1 0.01 58.14 JAUNDICE NEONATAL | 1 0.01 58.15 JAW DISORDER | 4 0.04 58.19 JOINT DISLOCATION | 2 0.02 58.21 JOINT EFFUSION | 1 0.01 58.22 JOINT INJURY | 1 0.01 58.23 JOINT RANGE OF MOTION DECREASED | 1 0.01 58.24 JOINT SPRAIN | 1 0.01 58.25 JOINT STIFFNESS | 3 0.03 58.28 JOINT SWELLING | 7 0.07 58.35 JUVENILE ARTHRITIS | 2 0.02 58.37 KELOID SCAR | 1 0.01 58.38 KERATITIS | 1 0.01 58.39 KIDNEY FIBROSIS | 2 0.02 58.41 KIDNEY INFECTION | 3 0.03 58.44 KIDNEY TRANSPLANT REJECTION | 4 0.04 58.48 KNEE ARTHROPLASTY | 4 0.04 58.52 LACERATION | 1 0.01 58.53 LACRIMATION INCREASED | 1 0.01 58.54 LACTIC ACIDOSIS | 4 0.04 58.58 LACTOSE INTOLERANCE | 1 0.01 58.59 LARGE INTESTINAL ULCER | 2 0.02 58.61 LARGE INTESTINE PERFORATION | 3 0.03 58.64 LARYNGEAL CANCER | 1 0.01 58.65 LARYNGEAL DISORDER | 2 0.02 58.67 LARYNGEAL OEDEMA | 4 0.04 58.71 LARYNGOTRACHEO BRONCHITIS | 1 0.01 58.72 LATEX ALLERGY | 1 0.01 58.73 LAZINESS | 1 0.01 58.74 LEFT VENTRICULAR FAILURE | 1 0.01 58.75 LEGAL PROBLEM | 1 0.01 58.76 LETHARGY | 14 0.14 58.90 LEUKAEMIA | 1 0.01 58.91 LEUKAEMIC RETINOPATHY | 2 0.02 58.93 LEUKOCYTOCLASTIC VASCULITIS | 3 0.03 58.96 LEUKOCYTOSIS | 12 0.12 59.08 LEUKOERYTHROBLASTIC ANAEMIA | 1 0.01 59.09 LEUKOPENIA | 22 0.22 59.31 LIBIDO DECREASED | 1 0.01 59.32 LIFE SUPPORT | 1 0.01 59.33 LIMB CRUSHING INJURY | 1 0.01 59.34 LIMB INJURY | 4 0.04 59.38 LIMB MALFORMATION | 1 0.01 59.39 LIMB REDUCTION DEFECT | 3 0.03 59.42 LIP DRY | 12 0.12 59.54 LIPASE INCREASED | 5 0.05 59.59 LIPODYSTROPHY ACQUIRED | 1 0.01 59.60 LIPOHYPERTROPHY | 2 0.02 59.62 LIPOMA | 2 0.02 59.64 LISTERIOSIS | 1 0.01 59.65 LIVEDO RETICULARIS | 2 0.02 59.67 LIVER DISORDER | 22 0.22 59.89 LIVER FUNCTION TEST ABNORMAL | 15 0.15 60.04 LIVER PALPABLE SUBCOSTAL | 1 0.01 60.05 LIVER TRANSPLANT | 4 0.04 60.09 LIVER TRANSPLANT REJECTION | 1 0.01 60.10 LOBAR PNEUMONIA | 1 0.01 60.11 LOCAL ANAESTHESIA | 2 0.02 60.13 LOCAL SWELLING | 3 0.03 60.16 LOCALISED INFECTION | 1 0.01 60.17 LOCALISED OEDEMA | 1 0.01 60.18 LOCKED-IN SYNDROME | 1 0.01 60.19 LOGORRHOEA | 2 0.02 60.21 LONG QT SYNDROME | 2 0.02 60.23 LOSS OF CONSCIOUSNESS | 39 0.39 60.62 LOSS OF LIBIDO | 1 0.01 60.63 LOW DENSITY LIPOPROTEIN INCREASED | 1 0.01 60.64 LOWER EXTREMITY MASS | 1 0.01 60.65 LOWER LIMB FRACTURE | 3 0.03 60.68 LOWER RESPIRATORY TRACT INFECTION | 1 0.01 60.69 LUMBAR PUNCTURE | 1 0.01 60.70 LUMBAR VERTEBRAL FRACTURE | 1 0.01 60.71 LUNG ABSCESS | 1 0.01 60.72 LUNG CANCER METASTATIC | 2 0.02 60.74 LUNG CONSOLIDATION | 1 0.01 60.75 LUNG DISORDER | 9 0.09 60.84 LUNG INFECTION | 2 0.02 60.86 LUNG INFECTION PSEUDOMONAL | 1 0.01 60.87 LUNG INFILTRATION | 8 0.08 60.95 LUNG NEOPLASM | 2 0.02 60.97 LUNG NEOPLASM MALIGNANT | 3 0.03 61.00 LUPUS NEPHRITIS | 1 0.01 61.01 LUPUS-LIKE SYNDROME | 3 0.03 61.04 LYME DISEASE | 1 0.01 61.05 LYMPH NODE PALPABLE | 1 0.01 61.06 LYMPH NODE TUBERCULOSIS | 2 0.02 61.08 LYMPHADENITIS | 1 0.01 61.09 LYMPHADENOPATHY | 7 0.07 61.16 LYMPHANGIOSIS CARCINOMATOSA | 1 0.01 61.17 LYMPHOCYTE COUNT DECREASED | 3 0.03 61.20 LYMPHOCYTE MORPHOLOGY ABNORMAL | 1 0.01 61.21 LYMPHOCYTE STIMULATION TEST POSITIVE | 2 0.02 61.23 LYMPHOCYTIC INFILTRATION | 1 0.01 61.24 LYMPHOMA | 4 0.04 61.28 LYMPHOPENIA | 1 0.01 61.29 LYMPHOPROLIFERATIVE DISORDER | 4 0.04 61.33 MACULAR DEGENERATION | 5 0.05 61.38 MACULAR OEDEMA | 14 0.14 61.52 MACULOPATHY | 1 0.01 61.53 MAJOR DEPRESSION | 3 0.03 61.56 MALAISE | 49 0.49 62.05 MALIGNANT NEOPLASM PROGRESSION | 11 0.11 62.16 MALIGNANT PLEURAL EFFUSION | 1 0.01 62.17 MALNUTRITION | 4 0.04 62.21 MAMMOGRAM ABNORMAL | 1 0.01 62.22 MANIA | 11 0.11 62.33 MARROW HYPERPLASIA | 1 0.01 62.34 MASS | 4 0.04 62.38 MASS EXCISION | 1 0.01 62.39 MASTECTOMY | 1 0.01 62.40 MASTICATION DISORDER | 2 0.02 62.42 MATERNAL CONDITION AFFECTING FOETUS | 1 0.01 62.43 MEAN CELL HAEMOGLOBIN INCREASED | 1 0.01 62.44 MEASLES | 1 0.01 62.45 MECONIUM ABNORMAL | 2 0.02 62.47 MEDIASTINAL MASS | 2 0.02 62.49 MEDICAL DEVICE COMPLICATION | 2 0.02 62.51 MEDICATION ERROR | 5 0.05 62.56 MEDULLOBLASTOMA | 1 0.01 62.57 MEGACOLON | 2 0.02 62.59 MELAENA | 9 0.09 62.68 MELANOCYTIC NAEVUS | 5 0.05 62.73 MELANOSIS | 1 0.01 62.74 MEMORY IMPAIRMENT | 10 0.10 62.84 MENINGIOMA | 2 0.02 62.86 MENINGIOMA BENIGN | 1 0.01 62.87 MENINGITIS | 2 0.02 62.89 MENINGITIS CRYPTOCOCCAL | 1 0.01 62.90 MENINGITIS LISTERIA | 1 0.01 62.91 MENINGITIS VIRAL | 1 0.01 62.92 MENINGOENCEPHALITIS ADENOVIRAL | 1 0.01 62.93 MENISCUS LESION | 5 0.05 62.98 MENOPAUSAL SYMPTOMS | 2 0.02 63.00 MENORRHAGIA | 3 0.03 63.03 MENSTRUATION IRREGULAR | 3 0.03 63.06 MENTAL DISORDER | 7 0.07 63.13 MENTAL IMPAIRMENT | 5 0.05 63.18 MENTAL STATUS CHANGES | 7 0.07 63.25 MESENTERIC ARTERY THROMBOSIS | 1 0.01 63.26 MESENTERIC VEIN THROMBOSIS | 1 0.01 63.27 MESOTHELIOMA | 1 0.01 63.28 METABOLIC ACIDOSIS | 11 0.11 63.39 METAL POISONING | 2 0.02 63.41 METASTASES TO BONE | 4 0.04 63.45 METASTASES TO CENTRAL NERVOUS SYSTEM | 1 0.01 63.46 METASTASES TO LIVER | 2 0.02 63.48 METASTASES TO LYMPH NODES | 2 0.02 63.50 METASTATIC NEOPLASM | 2 0.02 63.52 METASTATIC RENAL CELL CARCINOMA | 1 0.01 63.53 METHAEMOGLOBINAEMIA | 1 0.01 63.54 METRORRHAGIA | 4 0.04 63.58 MICROALBUMINURIA | 1 0.01 63.59 MICROANGIOPATHY | 1 0.01 63.60 MICROCEPHALY | 3 0.03 63.63 MICROCYTIC ANAEMIA | 1 0.01 63.64 MICTURITION DISORDER | 3 0.03 63.67 MICTURITION URGENCY | 2 0.02 63.69 MIDDLE LOBE SYNDROME | 1 0.01 63.70 MIGRAINE | 8 0.08 63.78 MIOSIS | 1 0.01 63.79 MITOCHONDRIAL CYTOPATHY | 1 0.01 63.80 MITOCHONDRIAL TOXICITY | 2 0.02 63.82 MITRAL VALVE CALCIFICATION | 1 0.01 63.83 MITRAL VALVE INCOMPETENCE | 1 0.01 63.84 MOBILITY DECREASED | 5 0.05 63.89 MONOCYTE PERCENTAGE DECREASED | 1 0.01 63.90 MONOPARESIS | 1 0.01 63.91 MONOPLEGIA | 1 0.01 63.92 MOOD ALTERED | 7 0.07 63.99 MOOD SWINGS | 6 0.06 64.05 MORBID THOUGHTS | 2 0.02 64.07 MOTION SICKNESS | 2 0.02 64.09 MOTOR DYSFUNCTION | 1 0.01 64.10 MOUTH HAEMORRHAGE | 2 0.02 64.12 MOUTH ULCERATION | 6 0.06 64.18 MOVEMENT DISORDER | 9 0.09 64.27 MUCOSAL DRYNESS | 1 0.01 64.28 MUCOSAL EROSION | 1 0.01 64.29 MUCOSAL HAEMORRHAGE | 1 0.01 64.30 MUCOSAL INFLAMMATION | 7 0.07 64.37 MUCOSAL ULCERATION | 2 0.02 64.39 MUCOUS MEMBRANE DISORDER | 1 0.01 64.40 MULTI-ORGAN DISORDER | 16 0.16 64.56 MULTI-ORGAN FAILURE | 6 0.06 64.62 MULTIPLE ALLERGIES | 1 0.01 64.63 MULTIPLE DRUG OVERDOSE | 2 0.02 64.65 MULTIPLE MYELOMA | 3 0.03 64.68 MULTIPLE PREGNANCY | 1 0.01 64.69 MULTIPLE SCLEROSIS | 2 0.02 64.71 MULTIPLE SCLEROSIS RELAPSE | 2 0.02 64.73 MUSCLE ATROPHY | 2 0.02 64.75 MUSCLE CONTRACTIONS INVOLUNTARY | 1 0.01 64.76 MUSCLE CONTRACTURE | 1 0.01 64.77 MUSCLE DISORDER | 1 0.01 64.78 MUSCLE ENZYME INCREASED | 1 0.01 64.79 MUSCLE FATIGUE | 1 0.01 64.80 MUSCLE HAEMORRHAGE | 1 0.01 64.81 MUSCLE INJURY | 2 0.02 64.83 MUSCLE NECROSIS | 1 0.01 64.84 MUSCLE RIGIDITY | 3 0.03 64.87 MUSCLE SPASMS | 20 0.20 65.07 MUSCLE STRAIN | 3 0.03 65.10 MUSCLE TIGHTNESS | 2 0.02 65.12 MUSCLE TWITCHING | 3 0.03 65.15 MUSCULAR WEAKNESS | 17 0.17 65.32 MUSCULOSKELETAL CHEST PAIN | 5 0.05 65.37 MUSCULOSKELETAL DISCOMFORT | 1 0.01 65.38 MUSCULOSKELETAL DISORDER | 4 0.04 65.42 MUSCULOSKELETAL PAIN | 3 0.03 65.45 MUSCULOSKELETAL STIFFNESS | 9 0.09 65.54 MYALGIA | 25 0.25 65.79 MYCOBACTERIAL INFECTION | 1 0.01 65.80 MYDRIASIS | 4 0.04 65.84 MYELITIS TRANSVERSE | 1 0.01 65.85 MYELODYSPLASTIC SYNDROME | 2 0.02 65.87 MYELOFIBROSIS | 2 0.02 65.89 MYELOID LEUKAEMIA | 1 0.01 65.90 MYOCARDIAL INFARCTION | 25 0.25 66.15 MYOCARDIAL ISCHAEMIA | 5 0.05 66.20 MYOCARDIAL RUPTURE | 1 0.01 66.21 MYOCARDITIS | 3 0.03 66.24 MYOCLONUS | 5 0.05 66.29 MYOGLOBIN BLOOD PRESENT | 1 0.01 66.30 MYOGLOBIN URINE PRESENT | 1 0.01 66.31 MYOPATHY | 2 0.02 66.33 MYOPIA | 1 0.01 66.34 MYOSITIS | 4 0.04 66.38 MYOTONIA | 1 0.01 66.39 NAIL DISORDER | 1 0.01 66.40 NAIL INFECTION | 1 0.01 66.41 NASAL CONGESTION | 1 0.01 66.42 NASAL DISCOMFORT | 2 0.02 66.44 NASAL DRYNESS | 5 0.05 66.49 NASAL FLARING | 1 0.01 66.50 NASAL MUCOSAL DISORDER | 1 0.01 66.51 NASAL NECROSIS | 1 0.01 66.52 NASAL SEPTUM PERFORATION | 1 0.01 66.53 NASOPHARYNGEAL DISORDER | 1 0.01 66.54 NASOPHARYNGITIS | 7 0.07 66.61 NAUSEA | 104 1.04 67.65 NECK INJURY | 4 0.04 67.69 NECK PAIN | 10 0.10 67.79 NECROSIS | 4 0.04 67.83 NECROTISING COLITIS | 2 0.02 67.85 NEGLECT OF PERSONAL APPEARANCE | 1 0.01 67.86 NEONATAL ASPIRATION | 3 0.03 67.89 NEONATAL DISORDER | 3 0.03 67.92 NEONATAL HYPOTENSION | 1 0.01 67.93 NEONATAL TACHYPNOEA | 2 0.02 67.95 NEOPLASM | 1 0.01 67.96 NEOPLASM MALIGNANT | 1 0.01 67.97 NEOPLASM PROGRESSION | 1 0.01 67.98 NEPHRITIS ALLERGIC | 1 0.01 67.99 NEPHRITIS INTERSTITIAL | 7 0.07 68.06 NEPHROGENIC DIABETES INSIPIDUS | 2 0.02 68.08 NEPHROGENIC FIBROSING DERMOPATHY | 1 0.01 68.09 NEPHROLITHIASIS | 15 0.15 68.24 NEPHROPATHY TOXIC | 3 0.03 68.27 NEPHROTIC SYNDROME | 6 0.06 68.33 NERVE COMPRESSION | 1 0.01 68.34 NERVOUS SYSTEM DISORDER | 7 0.07 68.41 NERVOUSNESS | 11 0.11 68.52 NEURALGIA | 1 0.01 68.53 NEUROBLASTOMA | 1 0.01 68.54 NEURODEGENERATIVE DISORDER | 1 0.01 68.55 NEUROLEPTIC MALIGNANT SYNDROME | 3 0.03 68.58 NEUROLOGICAL SYMPTOM | 2 0.02 68.60 NEUROMYOPATHY | 1 0.01 68.61 NEUROPATHIC ARTHROPATHY | 1 0.01 68.62 NEUROPATHY | 4 0.04 68.66 NEUROPATHY PERIPHERAL | 4 0.04 68.70 NEUROTOXICITY | 1 0.01 68.71 NEUTROPENIA | 23 0.23 68.94 NEUTROPENIC SEPSIS | 2 0.02 68.96 NEUTROPHIL COUNT DECREASED | 5 0.05 69.01 NEUTROPHIL MORPHOLOGY ABNORMAL | 2 0.02 69.03 NEUTROPHILIA | 2 0.02 69.05 NIGHT BLINDNESS | 3 0.03 69.08 NIGHT SWEATS | 5 0.05 69.13 NIGHTMARE | 11 0.11 69.24 NO ADVERSE EFFECT | 8 0.08 69.32 NO THERAPEUTIC RESPONSE | 1 0.01 69.33 NODULE | 1 0.01 69.34 NON-CARDIAC CHEST PAIN | 1 0.01 69.35 NON-HODGKIN'S LYMPHOMA | 4 0.04 69.39 NONSPECIFIC REACTION | 2 0.02 69.41 NORMAL NEWBORN | 4 0.04 69.45 NORMOCHROMIC NORMOCYTIC ANAEMIA | 1 0.01 69.46 NUCLEAR MAGNETIC RESONANCE IMAGING AB.. | 2 0.02 69.48 NUCLEAR MAGNETIC RESONANCE IMAGING BR.. | 3 0.03 69.51 OBLITERATIVE BRONCHIOLITIS | 1 0.01 69.52 OBSESSIVE THOUGHTS | 1 0.01 69.53 OBSESSIVE-COMPULSIVE DISORDER | 5 0.05 69.58 OBSTRUCTION | 2 0.02 69.60 OBSTRUCTIVE AIRWAYS DISORDER | 2 0.02 69.62 OCCULT BLOOD POSITIVE | 1 0.01 69.63 OCULAR HYPERAEMIA | 1 0.01 69.64 OCULAR ICTERUS | 3 0.03 69.67 ODYNOPHAGIA | 1 0.01 69.68 OEDEMA | 8 0.08 69.76 OEDEMA MOUTH | 1 0.01 69.77 OEDEMA PERIPHERAL | 32 0.32 70.09 OESOPHAGEAL CANDIDIASIS | 1 0.01 70.10 OESOPHAGEAL DISORDER | 1 0.01 70.11 OESOPHAGEAL STENOSIS | 3 0.03 70.14 OESOPHAGEAL ULCER | 2 0.02 70.16 OESOPHAGITIS | 10 0.10 70.26 OESOPHAGITIS CHEMICAL | 1 0.01 70.27 OESOPHAGITIS ULCERATIVE | 1 0.01 70.28 OLIGOHYDRAMNIOS | 1 0.01 70.29 OLIGURIA | 3 0.03 70.32 ONYCHOCLASIS | 1 0.01 70.33 OPTIC ATROPHY | 2 0.02 70.35 OPTIC NEURITIS | 1 0.01 70.36 OPTIC NEUROPATHY | 2 0.02 70.38 ORAL CANDIDIASIS | 6 0.06 70.44 ORAL CAVITY FISTULA | 1 0.01 70.45 ORAL DISCOMFORT | 1 0.01 70.46 ORAL HAIRY LEUKOPLAKIA | 1 0.01 70.47 ORAL INTAKE REDUCED | 10 0.10 70.57 ORAL PAIN | 3 0.03 70.60 ORAL SOFT TISSUE DISORDER | 3 0.03 70.63 ORAL SURGERY | 3 0.03 70.66 OROPHARYNGEAL SPASM | 1 0.01 70.67 ORTHOPEDIC PROCEDURE | 1 0.01 70.68 ORTHOPNOEA | 1 0.01 70.69 ORTHOSTATIC HYPOTENSION | 7 0.07 70.76 OSTEITIS | 4 0.04 70.80 OSTEITIS DEFORMANS | 1 0.01 70.81 OSTEOARTHRITIS | 3 0.03 70.84 OSTEOLYSIS | 1 0.01 70.85 OSTEOMALACIA | 1 0.01 70.86 OSTEOMYELITIS | 13 0.13 70.99 OSTEONECROSIS | 69 0.69 71.68 OSTEOPENIA | 3 0.03 71.71 OSTEOPOROSIS | 3 0.03 71.74 OSTEOSYNTHESIS | 1 0.01 71.75 OTITIS EXTERNA | 2 0.02 71.77 OVARIAN CANCER | 2 0.02 71.79 OVARIAN CYST | 5 0.05 71.84 OVARIAN CYST RUPTURED | 2 0.02 71.86 OVARIAN EPITHELIAL CANCER STAGE III | 1 0.01 71.87 OVERDOSE | 25 0.25 72.12 OXYGEN SATURATION DECREASED | 10 0.10 72.22 OXYGEN SUPPLEMENTATION | 1 0.01 72.23 PAIN | 57 0.57 72.80 PAIN IN EXTREMITY | 24 0.24 73.04 PAIN IN JAW | 9 0.09 73.13 PAIN OF SKIN | 1 0.01 73.14 PALATAL OEDEMA | 1 0.01 73.15 PALLOR | 10 0.10 73.25 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SY.. | 3 0.03 73.28 PALPITATIONS | 17 0.17 73.45 PANCREAS INFECTION | 1 0.01 73.46 PANCREATIC CARCINOMA | 1 0.01 73.47 PANCREATIC CYST | 1 0.01 73.48 PANCREATIC ENZYMES INCREASED | 4 0.04 73.52 PANCREATIC FISTULA | 1 0.01 73.53 PANCREATIC LESION EXCISION | 1 0.01 73.54 PANCREATIC NEOPLASM | 1 0.01 73.55 PANCREATIC PSEUDOCYST | 1 0.01 73.56 PANCREATITIS | 12 0.12 73.68 PANCREATITIS ACUTE | 3 0.03 73.71 PANCREATITIS CHRONIC | 2 0.02 73.73 PANCREATITIS HAEMORRHAGIC | 1 0.01 73.74 PANCYTOPENIA | 19 0.19 73.93 PANIC ATTACK | 9 0.09 74.02 PANIC DISORDER | 2 0.02 74.04 PANIC REACTION | 2 0.02 74.06 PAPILLOEDEMA | 1 0.01 74.07 PAPILLOMA VIRAL INFECTION | 2 0.02 74.09 PARADOXICAL DRUG REACTION | 1 0.01 74.10 PARAESTHESIA | 33 0.33 74.43 PARAINFLUENZAE VIRUS INFECTION | 1 0.01 74.44 PARALYSIS | 3 0.03 74.47 PARANOIA | 8 0.08 74.55 PARAPLEGIA | 1 0.01 74.56 PARAPSORIASIS | 1 0.01 74.57 PARATHYROID TUMOUR BENIGN | 1 0.01 74.58 PARESIS | 4 0.04 74.62 PARKINSON'S DISEASE | 2 0.02 74.64 PAROSMIA | 1 0.01 74.65 PAROVARIAN CYST | 1 0.01 74.66 PARVOVIRUS INFECTION | 1 0.01 74.67 PATENT DUCTUS ARTERIOSUS | 1 0.01 74.68 PCO2 DECREASED | 1 0.01 74.69 PCO2 INCREASED | 1 0.01 74.70 PELVIC FRACTURE | 3 0.03 74.73 PELVIC INFLAMMATORY DISEASE | 1 0.01 74.74 PELVIC MASS | 1 0.01 74.75 PEMPHIGOID | 2 0.02 74.77 PERFORMANCE FEAR | 1 0.01 74.78 PERFORMANCE STATUS DECREASED | 7 0.07 74.85 PERIANAL ABSCESS | 1 0.01 74.86 PERICARDIAL EFFUSION | 6 0.06 74.92 PERICARDIAL HAEMORRHAGE | 1 0.01 74.93 PERICARDITIS | 4 0.04 74.97 PERINEPHRIC ABSCESS | 1 0.01 74.98 PERINEPHRIC COLLECTION | 2 0.02 75.00 PERIODONTITIS | 1 0.01 75.01 PERIORBITAL CELLULITIS | 1 0.01 75.02 PERIORBITAL OEDEMA | 3 0.03 75.05 PERIPHERAL ISCHAEMIA | 1 0.01 75.06 PERIPHERAL MOTOR NEUROPATHY | 1 0.01 75.07 PERIRECTAL ABSCESS | 4 0.04 75.11 PERITONEAL CARCINOMA | 1 0.01 75.12 PERITONEAL TUBERCULOSIS | 1 0.01 75.13 PERITONITIS | 4 0.04 75.17 PERITONITIS BACTERIAL | 1 0.01 75.18 PERITONSILLAR ABSCESS | 1 0.01 75.19 PERONEAL NERVE PALSY | 1 0.01 75.20 PERSEVERATION | 1 0.01 75.21 PERSONALITY CHANGE | 2 0.02 75.23 PERSONALITY DISORDER | 1 0.01 75.24 PETECHIAE | 3 0.03 75.27 PETIT MAL EPILEPSY | 1 0.01 75.28 PHARMACEUTICAL PRODUCT COMPLAINT | 46 0.46 75.74 PHARMACEUTICAL PRODUCT COUNTERFEIT | 1 0.01 75.75 PHARYNGEAL ERYTHEMA | 1 0.01 75.76 PHARYNGEAL OEDEMA | 6 0.06 75.82 PHARYNGEAL ULCERATION | 1 0.01 75.83 PHARYNGITIS | 7 0.07 75.90 PHARYNGOESOPHAGEAL DIVERTICULUM | 1 0.01 75.91 PHARYNGOLARYNGEAL DISCOMFORT | 1 0.01 75.92 PHARYNGOLARYNGEAL PAIN | 12 0.12 76.04 PHLEBITIS | 6 0.06 76.10 PHONOLOGICAL DISORDER | 1 0.01 76.11 PHOTOPHOBIA | 3 0.03 76.14 PHOTOPSIA | 1 0.01 76.15 PHOTOSENSITIVITY REACTION | 3 0.03 76.18 PHYSICAL ASSAULT | 1 0.01 76.19 PILONIDAL CYST | 2 0.02 76.21 PITUITARY TUMOUR | 1 0.01 76.22 PITUITARY TUMOUR BENIGN | 1 0.01 76.23 PITUITARY TUMOUR RECURRENT | 1 0.01 76.24 PITUITARY-DEPENDENT CUSHING'S SYNDROME | 1 0.01 76.25 PLACENTAL DISORDER | 5 0.05 76.30 PLACENTAL INFARCTION | 2 0.02 76.32 PLACENTAL INSUFFICIENCY | 1 0.01 76.33 PLACENTAL NECROSIS | 1 0.01 76.34 PLASTIC SURGERY | 5 0.05 76.39 PLATELET AGGREGATION INHIBITION | 1 0.01 76.40 PLATELET COUNT DECREASED | 42 0.42 76.82 PLATELET COUNT INCREASED | 3 0.03 76.85 PLEOCYTOSIS | 2 0.02 76.87 PLEURAL EFFUSION | 23 0.23 77.10 PLEURAL FIBROSIS | 1 0.01 77.11 PLEURISY | 2 0.02 77.13 PLEURITIC PAIN | 1 0.01 77.14 PLEUROPERICARDITIS | 1 0.01 77.15 PNEUMATOSIS | 2 0.02 77.17 PNEUMOCYSTIS JIROVECI PNEUMONIA | 4 0.04 77.21 PNEUMONIA | 40 0.40 77.61 PNEUMONIA ASPIRATION | 3 0.03 77.64 PNEUMONIA FUNGAL | 1 0.01 77.65 PNEUMONIA PNEUMOCOCCAL | 1 0.01 77.66 PNEUMONIA STAPHYLOCOCCAL | 2 0.02 77.68 PNEUMONIA VIRAL | 2 0.02 77.70 PNEUMONITIS | 4 0.04 77.74 PNEUMONITIS CHEMICAL | 1 0.01 77.75 PNEUMOTHORAX | 5 0.05 77.80 PO2 INCREASED | 1 0.01 77.81 POIKILOCYTOSIS | 1 0.01 77.82 POISONING | 1 0.01 77.83 POLLAKIURIA | 9 0.09 77.92 POLYARTHRITIS | 4 0.04 77.96 POLYCYSTIC OVARIES | 1 0.01 77.97 POLYDACTYLY | 1 0.01 77.98 POLYDIPSIA | 1 0.01 77.99 POLYHYDRAMNIOS | 1 0.01 78.00 POLYMYOSITIS | 2 0.02 78.02 POLYNEUROPATHY | 2 0.02 78.04 POLYP | 2 0.02 78.06 POLYTRAUMATISM | 1 0.01 78.07 POLYURIA | 2 0.02 78.09 POOR PERIPHERAL CIRCULATION | 2 0.02 78.11 POOR QUALITY DRUG ADMINISTERED | 3 0.03 78.14 POOR SUCKING REFLEX | 2 0.02 78.16 POOR WEIGHT GAIN NEONATAL | 1 0.01 78.17 PORTAL HYPERTENSIVE GASTROPATHY | 2 0.02 78.19 POST PROCEDURAL COMPLICATION | 9 0.09 78.28 POST PROCEDURAL HAEMATOMA | 1 0.01 78.29 POST PROCEDURAL HAEMORRHAGE | 2 0.02 78.31 POST-TRAUMATIC PAIN | 1 0.01 78.32 POSTNASAL DRIP | 2 0.02 78.34 POSTOPERATIVE ADHESION | 1 0.01 78.35 POSTOPERATIVE INFECTION | 1 0.01 78.36 POSTPARTUM DEPRESSION | 1 0.01 78.37 POUCHITIS | 1 0.01 78.38 PRE-ECLAMPSIA | 1 0.01 78.39 PRECANCEROUS CELLS PRESENT | 1 0.01 78.40 PREGNANCY | 20 0.20 78.60 PREGNANCY OF PARTNER | 1 0.01 78.61 PREGNANCY ON ORAL CONTRACEPTIVE | 3 0.03 78.64 PREGNANCY TEST POSITIVE | 3 0.03 78.67 PREGNANCY TEST URINE POSITIVE | 1 0.01 78.68 PREGNANCY WITH CONTRACEPTIVE DEVICE | 1 0.01 78.69 PREMATURE BABY | 12 0.12 78.81 PREMATURE LABOUR | 4 0.04 78.85 PREMATURE RUPTURE OF MEMBRANES | 2 0.02 78.87 PRESBYOESOPHAGUS | 1 0.01 78.88 PRESCRIBED OVERDOSE | 7 0.07 78.95 PRIMARY SEQUESTRUM | 1 0.01 78.96 PROCEDURAL COMPLICATION | 4 0.04 79.00 PROCTALGIA | 2 0.02 79.02 PROCTITIS | 7 0.07 79.09 PROCTITIS ULCERATIVE | 2 0.02 79.11 PROCTOCOLITIS | 1 0.01 79.12 PRODUCTIVE COUGH | 7 0.07 79.19 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALO.. | 2 0.02 79.21 PROSTATE CANCER | 1 0.01 79.22 PROSTATE EXAMINATION ABNORMAL | 1 0.01 79.23 PROSTATIC DISORDER | 1 0.01 79.24 PROSTATIC HAEMORRHAGE | 1 0.01 79.25 PROSTATIC SPECIFIC ANTIGEN INCREASED | 2 0.02 79.27 PROSTATITIS | 1 0.01 79.28 PROSTHESIS IMPLANTATION | 1 0.01 79.29 PROTEIN TOTAL DECREASED | 6 0.06 79.35 PROTEIN URINE PRESENT | 1 0.01 79.36 PROTEINURIA | 7 0.07 79.43 PROTHROMBIN LEVEL DECREASED | 6 0.06 79.49 PROTHROMBIN TIME PROLONGED | 7 0.07 79.56 PRURITUS | 27 0.27 79.83 PRURITUS ANI | 2 0.02 79.85 PRURITUS GENERALISED | 5 0.05 79.90 PSEUDARTHROSIS | 1 0.01 79.91 PSEUDO-BARTTER SYNDROME | 2 0.02 79.93 PSEUDOMEMBRANOUS COLITIS | 3 0.03 79.96 PSEUDOMONAS INFECTION | 1 0.01 79.97 PSEUDOPOLYPOSIS | 1 0.01 79.98 PSORIASIS | 7 0.07 80.05 PSYCHIATRIC SYMPTOM | 3 0.03 80.08 PSYCHOMOTOR HYPERACTIVITY | 3 0.03 80.11 PSYCHOMOTOR RETARDATION | 1 0.01 80.12 PSYCHOMOTOR SKILLS IMPAIRED | 2 0.02 80.14 PSYCHOTIC DISORDER | 11 0.11 80.25 PULMONARY ALVEOLAR HAEMORRHAGE | 1 0.01 80.26 PULMONARY CONGESTION | 6 0.06 80.32 PULMONARY EMBOLISM | 14 0.14 80.46 PULMONARY FIBROSIS | 6 0.06 80.52 PULMONARY HAEMORRHAGE | 3 0.03 80.55 PULMONARY HYPERTENSION | 5 0.05 80.60 PULMONARY INFARCTION | 1 0.01 80.61 PULMONARY MYCOSIS | 1 0.01 80.62 PULMONARY OEDEMA | 9 0.09 80.71 PULMONARY TUBERCULOSIS | 2 0.02 80.73 PULMONARY VALVE INCOMPETENCE | 1 0.01 80.74 PULMONARY VALVE STENOSIS | 1 0.01 80.75 PULSE ABNORMAL | 1 0.01 80.76 PULSE ABSENT | 2 0.02 80.78 PURPURA | 8 0.08 80.86 PURULENCE | 3 0.03 80.89 PURULENT DISCHARGE | 6 0.06 80.95 PUSTULAR PSORIASIS | 4 0.04 80.99 PYELONEPHRITIS | 1 0.01 81.00 PYELONEPHRITIS ACUTE | 2 0.02 81.02 PYODERMA GANGRENOSUM | 1 0.01 81.03 PYREXIA | 99 0.99 82.02 PYURIA | 3 0.03 82.05 RADIATION EXPOSURE | 1 0.01 82.06 RADIATION OESOPHAGITIS | 1 0.01 82.07 RADIATION SKIN INJURY | 1 0.01 82.08 RADICULAR PAIN | 1 0.01 82.09 RADICULOPATHY | 1 0.01 82.10 RALES | 3 0.03 82.13 RASH | 47 0.47 82.60 RASH ERYTHEMATOUS | 6 0.06 82.66 RASH GENERALISED | 4 0.04 82.70 RASH MACULAR | 4 0.04 82.74 RASH MACULO-PAPULAR | 7 0.07 82.81 RASH PAPULAR | 2 0.02 82.83 RASH PRURITIC | 6 0.06 82.89 RASH PUSTULAR | 3 0.03 82.92 RAYNAUD'S PHENOMENON | 2 0.02 82.94 REACTION TO AZO-DYES | 1 0.01 82.95 REACTION TO DRUG EXCIPIENTS | 1 0.01 82.96 RECTAL CANCER | 4 0.04 83.00 RECTAL CANCER METASTATIC | 1 0.01 83.01 RECTAL HAEMORRHAGE | 25 0.25 83.26 RECTAL PERFORATION | 1 0.01 83.27 RED BLOOD CELL COUNT DECREASED | 13 0.13 83.40 RED BLOOD CELL COUNT INCREASED | 1 0.01 83.41 RED BLOOD CELL SEDIMENTATION RATE INC.. | 6 0.06 83.47 RED BLOOD CELL TARGET CELLS PRESENT | 1 0.01 83.48 REFLUX OESOPHAGITIS | 1 0.01 83.49 REFUSAL OF TREATMENT BY PATIENT | 2 0.02 83.51 REMOVAL OF RENAL TRANSPLANT | 1 0.01 83.52 RENAL AMYLOIDOSIS | 1 0.01 83.53 RENAL ANEURYSM | 1 0.01 83.54 RENAL ARTERIOSCLEROSIS | 1 0.01 83.55 RENAL ARTERY STENOSIS | 1 0.01 83.56 RENAL CANCER METASTATIC | 2 0.02 83.58 RENAL CELL CARCINOMA STAGE UNSPECIFIED | 6 0.06 83.64 RENAL COLIC | 2 0.02 83.66 RENAL DISORDER | 9 0.09 83.75 RENAL FAILURE | 48 0.48 84.23 RENAL FAILURE ACUTE | 41 0.41 84.64 RENAL FAILURE CHRONIC | 1 0.01 84.65 RENAL IMPAIRMENT | 14 0.14 84.79 RENAL INFARCT | 1 0.01 84.80 RENAL INJURY | 1 0.01 84.81 RENAL LYMPHOCELE | 1 0.01 84.82 RENAL PAIN | 4 0.04 84.86 RENAL TUBULAR ACIDOSIS | 1 0.01 84.87 RENAL TUBULAR ATROPHY | 1 0.01 84.88 RENAL TUBULAR DISORDER | 4 0.04 84.92 RENAL TUBULAR NECROSIS | 5 0.05 84.97 RENIN INCREASED | 1 0.01 84.98 RENOVASCULAR HYPERTENSION | 1 0.01 84.99 RESPIRATORY ACIDOSIS | 1 0.01 85.00 RESPIRATORY ARREST | 4 0.04 85.04 RESPIRATORY DEPRESSION | 2 0.02 85.06 RESPIRATORY DISORDER | 4 0.04 85.10 RESPIRATORY DISTRESS | 10 0.10 85.20 RESPIRATORY FAILURE | 16 0.16 85.36 RESPIRATORY GAS EXCHANGE DISORDER | 1 0.01 85.37 RESPIRATORY RATE DECREASED | 2 0.02 85.39 RESPIRATORY RATE INCREASED | 6 0.06 85.45 RESPIRATORY TRACT INFECTION | 1 0.01 85.46 RESTLESS LEGS SYNDROME | 1 0.01 85.47 RESTLESSNESS | 14 0.14 85.61 RESTRICTIVE CARDIOMYOPATHY | 1 0.01 85.62 RESUSCITATION | 2 0.02 85.64 RETCHING | 3 0.03 85.67 RETINAL ANEURYSM | 2 0.02 85.69 RETINAL ARTERY OCCLUSION | 1 0.01 85.70 RETINAL DETACHMENT | 3 0.03 85.73 RETINAL DISORDER | 2 0.02 85.75 RETINAL EXUDATES | 1 0.01 85.76 RETINAL HAEMORRHAGE | 5 0.05 85.81 RETINAL ISCHAEMIA | 4 0.04 85.85 RETINAL NEOVASCULARISATION | 2 0.02 85.87 RETINAL VASCULAR DISORDER | 1 0.01 85.88 RETINAL VEIN OCCLUSION | 1 0.01 85.89 RETINITIS PIGMENTOSA | 1 0.01 85.90 RETINOPATHY | 3 0.03 85.93 RETROPERITONEAL FIBROSIS | 1 0.01 85.94 RETROPERITONEAL HAEMATOMA | 1 0.01 85.95 REVERSIBLE POSTERIOR LEUKOENCEPHALOPA.. | 2 0.02 85.97 RHABDOMYOLYSIS | 21 0.21 86.18 RHEUMATOID ARTHRITIS | 2 0.02 86.20 RHINALGIA | 1 0.01 86.21 RHINITIS | 3 0.03 86.24 RHINORRHOEA | 2 0.02 86.26 RIB FRACTURE | 4 0.04 86.30 RIGHT VENTRICULAR SYSTOLIC PRESSURE I.. | 1 0.01 86.31 ROAD TRAFFIC ACCIDENT | 14 0.14 86.45 ROSACEA | 1 0.01 86.46 SACROILIITIS | 1 0.01 86.47 SARCOIDOSIS | 1 0.01 86.48 SCAPULA FRACTURE | 1 0.01 86.49 SCAR | 2 0.02 86.51 SCEDOSPORIUM INFECTION | 1 0.01 86.52 SCHIZOPHRENIA | 4 0.04 86.56 SCIATICA | 1 0.01 86.57 SCLERODERMA | 1 0.01 86.58 SCOLIOSIS | 1 0.01 86.59 SCOTOMA | 2 0.02 86.61 SCREAMING | 1 0.01 86.62 SEASONAL ALLERGY | 2 0.02 86.64 SECRETION DISCHARGE | 2 0.02 86.66 SEDATION | 3 0.03 86.69 SELECTIVE IGA IMMUNODEFICIENCY | 1 0.01 86.70 SELF INJURIOUS BEHAVIOUR | 1 0.01 86.71 SELF MUTILATION | 2 0.02 86.73 SELF-MEDICATION | 1 0.01 86.74 SEMEN ABNORMAL | 1 0.01 86.75 SEMEN VOLUME ABNORMAL | 1 0.01 86.76 SENSATION OF BLOOD FLOW | 1 0.01 86.77 SENSATION OF FOREIGN BODY | 1 0.01 86.78 SENSATION OF PRESSURE | 1 0.01 86.79 SENSITIVITY OF TEETH | 1 0.01 86.80 SENSORY DISTURBANCE | 3 0.03 86.83 SENSORY LEVEL ABNORMAL | 1 0.01 86.84 SENSORY LOSS | 2 0.02 86.86 SEPSIS | 20 0.20 87.06 SEPTIC SHOCK | 11 0.11 87.17 SEQUESTRECTOMY | 1 0.01 87.18 SEROMA | 1 0.01 87.19 SERUM FERRITIN DECREASED | 1 0.01 87.20 SEXUAL DYSFUNCTION | 3 0.03 87.23 SHOCK | 14 0.14 87.37 SHOCK HAEMORRHAGIC | 3 0.03 87.40 SHOCK HYPOGLYCAEMIC | 2 0.02 87.42 SICK SINUS SYNDROME | 1 0.01 87.43 SICKLE CELL ANAEMIA WITH CRISIS | 2 0.02 87.45 SIGMOIDECTOMY | 1 0.01 87.46 SIGMOIDITIS | 1 0.01 87.47 SIMPLE PARTIAL SEIZURES | 4 0.04 87.51 SINOATRIAL BLOCK | 1 0.01 87.52 SINUS BRADYCARDIA | 1 0.01 87.53 SINUS CONGESTION | 1 0.01 87.54 SINUS DISORDER | 2 0.02 87.56 SINUS HEADACHE | 1 0.01 87.57 SINUS TACHYCARDIA | 8 0.08 87.65 SINUSITIS | 8 0.08 87.73 SJOGREN'S SYNDROME | 2 0.02 87.75 SKIN CANCER | 1 0.01 87.76 SKIN DEPIGMENTATION | 1 0.01 87.77 SKIN DISCOLOURATION | 4 0.04 87.81 SKIN DISORDER | 5 0.05 87.86 SKIN EXFOLIATION | 10 0.10 87.96 SKIN FRAGILITY | 1 0.01 87.97 SKIN GRAFT | 1 0.01 87.98 SKIN HAEMORRHAGE | 3 0.03 88.01 SKIN HYPERPIGMENTATION | 1 0.01 88.02 SKIN HYPOPIGMENTATION | 1 0.01 88.03 SKIN INFECTION | 2 0.02 88.05 SKIN LACERATION | 4 0.04 88.09 SKIN LESION | 2 0.02 88.11 SKIN NECROSIS | 1 0.01 88.12 SKIN NODULE | 1 0.01 88.13 SKIN PAPILLOMA | 4 0.04 88.17 SKIN REACTION | 4 0.04 88.21 SKIN SWELLING | 1 0.01 88.22 SKIN ULCER | 6 0.06 88.28 SLEEP APNOEA SYNDROME | 1 0.01 88.29 SLEEP DISORDER | 5 0.05 88.34 SLEEP TERROR | 1 0.01 88.35 SLEEP WALKING | 1 0.01 88.36 SLUGGISHNESS | 2 0.02 88.38 SMALL CELL LUNG CANCER STAGE UNSPECIF.. | 1 0.01 88.39 SMALL FOR DATES BABY | 2 0.02 88.41 SMALL INTESTINAL OBSTRUCTION | 3 0.03 88.44 SMALL INTESTINAL PERFORATION | 1 0.01 88.45 SMALL INTESTINE CARCINOMA | 1 0.01 88.46 SMALL INTESTINE ULCER | 1 0.01 88.47 SNEEZING | 2 0.02 88.49 SOCIAL FEAR | 1 0.01 88.50 SOCIAL PHOBIA | 1 0.01 88.51 SOFT TISSUE DISORDER | 1 0.01 88.52 SOFT TISSUE HAEMORRHAGE | 1 0.01 88.53 SOFT TISSUE INFECTION | 1 0.01 88.54 SOMNOLENCE | 35 0.35 88.89 SPECIFIC GRAVITY URINE DECREASED | 1 0.01 88.90 SPEECH DISORDER | 8 0.08 88.98 SPERM COUNT DECREASED | 1 0.01 88.99 SPERMATOZOA PROGRESSIVE MOTILITY ABNO.. | 1 0.01 89.00 SPINA BIFIDA | 1 0.01 89.01 SPINAL COMPRESSION FRACTURE | 1 0.01 89.02 SPINAL DISORDER | 1 0.01 89.03 SPINAL LAMINECTOMY | 1 0.01 89.04 SPINAL OSTEOARTHRITIS | 1 0.01 89.05 SPINAL X-RAY ABNORMAL | 1 0.01 89.06 SPLENECTOMY | 1 0.01 89.07 SPLENIC CYST | 1 0.01 89.08 SPLENOMEGALY | 7 0.07 89.15 SPONDYLOARTHROPATHY | 2 0.02 89.17 SPONTANEOUS HAEMATOMA | 1 0.01 89.18 SPORTS INJURY | 2 0.02 89.20 SPUTUM CULTURE POSITIVE | 2 0.02 89.22 SPUTUM PURULENT | 2 0.02 89.24 SQUAMOUS CELL CARCINOMA | 5 0.05 89.29 STAPHYLOCOCCAL INFECTION | 14 0.14 89.43 STAPHYLOCOCCAL SEPSIS | 2 0.02 89.45 STARING | 1 0.01 89.46 STATUS EPILEPTICUS | 5 0.05 89.51 STENT OCCLUSION | 2 0.02 89.53 STENT PLACEMENT | 1 0.01 89.54 STEREOTYPIC MOVEMENT DISORDER | 1 0.01 89.55 STEVENS-JOHNSON SYNDROME | 5 0.05 89.60 STIFF-MAN SYNDROME | 1 0.01 89.61 STILLBIRTH | 7 0.07 89.68 STOMACH DISCOMFORT | 6 0.06 89.74 STOMATITIS | 14 0.14 89.88 STOMATITIS NECROTISING | 2 0.02 89.90 STRABISMUS | 2 0.02 89.92 STREPTOCOCCAL INFECTION | 1 0.01 89.93 STRESS | 7 0.07 90.00 STRIDOR | 1 0.01 90.01 SUBARACHNOID HAEMORRHAGE | 1 0.01 90.02 SUBCUTANEOUS ABSCESS | 1 0.01 90.03 SUBDURAL HAEMATOMA | 1 0.01 90.04 SUDDEN DEATH | 2 0.02 90.06 SUDDEN ONSET OF SLEEP | 1 0.01 90.07 SUFFOCATION FEELING | 3 0.03 90.10 SUICIDAL BEHAVIOUR | 1 0.01 90.11 SUICIDAL IDEATION | 39 0.39 90.50 SUICIDE ATTEMPT | 19 0.19 90.69 SUNBURN | 1 0.01 90.70 SUPERINFECTION | 1 0.01 90.71 SUPRAVENTRICULAR EXTRASYSTOLES | 1 0.01 90.72 SUPRAVENTRICULAR TACHYCARDIA | 5 0.05 90.77 SURGERY | 8 0.08 90.85 SURGICAL PROCEDURE REPEATED | 1 0.01 90.86 SWELLING | 15 0.15 91.01 SWELLING FACE | 9 0.09 91.10 SWOLLEN TONGUE | 4 0.04 91.14 SYNCOPE | 21 0.21 91.35 SYNCOPE VASOVAGAL | 1 0.01 91.36 SYNOVIAL CYST | 2 0.02 91.38 SYNOVIAL RUPTURE | 1 0.01 91.39 SYSTEMIC CANDIDA | 1 0.01 91.40 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME | 1 0.01 91.41 SYSTEMIC LUPUS ERYTHEMATOSUS | 7 0.07 91.48 TACHYARRHYTHMIA | 2 0.02 91.50 TACHYCARDIA | 25 0.25 91.75 TACHYPNOEA | 3 0.03 91.78 TARDIVE DYSKINESIA | 4 0.04 91.82 TELANGIECTASIA | 1 0.01 91.83 TEMPERATURE INTOLERANCE | 1 0.01 91.84 TEMPORAL ARTERITIS | 1 0.01 91.85 TEMPOROMANDIBULAR JOINT SYNDROME | 1 0.01 91.86 TENDERNESS | 5 0.05 91.91 TENDON DISORDER | 3 0.03 91.94 TENDON INJURY | 1 0.01 91.95 TENDON RUPTURE | 2 0.02 91.97 TENDONITIS | 5 0.05 92.02 TENSION HEADACHE | 1 0.01 92.03 TESTICULAR NEOPLASM | 1 0.01 92.04 TESTICULAR OPERATION | 1 0.01 92.05 TESTICULAR PAIN | 3 0.03 92.08 TETANUS | 1 0.01 92.09 THERAPEUTIC AGENT TOXICITY | 2 0.02 92.11 THERAPEUTIC RESPONSE DECREASED | 5 0.05 92.16 THERAPEUTIC RESPONSE UNEXPECTED | 1 0.01 92.17 THERAPEUTIC RESPONSE UNEXPECTED WITH .. | 4 0.04 92.21 THERAPY NON-RESPONDER | 10 0.10 92.31 THERMAL BURN | 1 0.01 92.32 THINKING ABNORMAL | 4 0.04 92.36 THIRST | 4 0.04 92.40 THORACIC VERTEBRAL FRACTURE | 1 0.01 92.41 THROAT IRRITATION | 3 0.03 92.44 THROAT TIGHTNESS | 4 0.04 92.48 THROMBOANGIITIS OBLITERANS | 1 0.01 92.49 THROMBOCYTHAEMIA | 1 0.01 92.50 THROMBOCYTOPENIA | 35 0.35 92.85 THROMBOCYTOPENIC PURPURA | 2 0.02 92.87 THROMBOSIS | 10 0.10 92.97 THROMBOSIS IN DEVICE | 2 0.02 92.99 THROMBOTIC THROMBOCYTOPENIC PURPURA | 2 0.02 93.01 THYMUS DISORDER | 1 0.01 93.02 THYROID DISORDER | 1 0.01 93.03 THYROID NEOPLASM | 1 0.01 93.04 THYROID OPERATION | 1 0.01 93.05 TIBIA FRACTURE | 3 0.03 93.08 TIC | 3 0.03 93.11 TINNITUS | 9 0.09 93.20 TOE AMPUTATION | 1 0.01 93.21 TONGUE DISORDER | 1 0.01 93.22 TONGUE OEDEMA | 1 0.01 93.23 TONGUE PARALYSIS | 1 0.01 93.24 TONGUE ULCERATION | 1 0.01 93.25 TONSILLAR DISORDER | 1 0.01 93.26 TONSILLITIS | 2 0.02 93.28 TOOTH ABSCESS | 12 0.12 93.40 TOOTH DEPOSIT | 1 0.01 93.41 TOOTH DEVELOPMENT DISORDER | 1 0.01 93.42 TOOTH DISCOLOURATION | 1 0.01 93.43 TOOTH DISORDER | 3 0.03 93.46 TOOTH EROSION | 1 0.01 93.47 TOOTH EXTRACTION | 27 0.27 93.74 TOOTH FRACTURE | 1 0.01 93.75 TOOTH INFECTION | 2 0.02 93.77 TOOTH LOSS | 2 0.02 93.79 TOOTHACHE | 1 0.01 93.80 TORSADE DE POINTES | 1 0.01 93.81 TORTICOLLIS | 1 0.01 93.82 TOXIC EPIDERMAL NECROLYSIS | 2 0.02 93.84 TOXIC INDUCED ENCEPHALOPATHY | 1 0.01 93.85 TOXIC SKIN ERUPTION | 5 0.05 93.90 TOXOPLASMOSIS | 1 0.01 93.91 TRACHEAL HAEMORRHAGE | 1 0.01 93.92 TRACHEITIS | 1 0.01 93.93 TRANSAMINASES INCREASED | 8 0.08 94.01 TRANSIENT ISCHAEMIC ATTACK | 2 0.02 94.03 TRANSMISSION OF DRUG VIA SEMEN | 1 0.01 94.04 TRANSPLANT | 1 0.01 94.05 TRANSPLANT REJECTION | 1 0.01 94.06 TRAUMATIC BRAIN INJURY | 1 0.01 94.07 TREATMENT NONCOMPLIANCE | 12 0.12 94.19 TREATMENT RELATED SECONDARY MALIGNANCY | 6 0.06 94.25 TREMOR | 28 0.28 94.53 TRICHIASIS | 1 0.01 94.54 TRICHOTILLOMANIA | 1 0.01 94.55 TRICUSPID VALVE INCOMPETENCE | 4 0.04 94.59 TRIGGER FINGER | 1 0.01 94.60 TRISOMY 21 | 2 0.02 94.62 TRYPTASE INCREASED | 1 0.01 94.63 TUBERCULOSIS | 4 0.04 94.67 TUBERCULOSIS BLADDER | 1 0.01 94.68 TUBERCULOUS PLEURISY | 2 0.02 94.70 TUBULOINTERSTITIAL NEPHRITIS | 2 0.02 94.72 TUMOUR NECROSIS | 1 0.01 94.73 TWIN PREGNANCY | 2 0.02 94.75 TYPE IV HYPERSENSITIVITY REACTION | 1 0.01 94.76 ULCER | 4 0.04 94.80 ULCER HAEMORRHAGE | 3 0.03 94.83 ULTRASOUND ABDOMEN ABNORMAL | 1 0.01 94.84 ULTRASOUND SCAN ABNORMAL | 1 0.01 94.85 UMBILICAL HERNIA | 2 0.02 94.87 UNDERWEIGHT | 1 0.01 94.88 UNEVALUABLE EVENT | 6 0.06 94.94 UNINTENDED PREGNANCY | 3 0.03 94.97 UNWANTED PREGNANCY | 3 0.03 95.00 UPPER GASTROINTESTINAL HAEMORRHAGE | 2 0.02 95.02 UPPER LIMB FRACTURE | 5 0.05 95.07 UPPER RESPIRATORY TRACT INFECTION | 9 0.09 95.16 UPPER RESPIRATORY TRACT INFLAMMATION | 2 0.02 95.18 UREA URINE DECREASED | 1 0.01 95.19 URINARY CASTS | 1 0.01 95.20 URINARY INCONTINENCE | 5 0.05 95.25 URINARY RETENTION | 9 0.09 95.34 URINARY TRACT DISORDER | 1 0.01 95.35 URINARY TRACT INFECTION | 15 0.15 95.50 URINARY TRACT INFECTION BACTERIAL | 1 0.01 95.51 URINE ANALYSIS ABNORMAL | 2 0.02 95.53 URINE FLOW DECREASED | 1 0.01 95.54 URINE OUTPUT DECREASED | 5 0.05 95.59 URINE PHOSPHATE DECREASED | 1 0.01 95.60 URINE SODIUM DECREASED | 1 0.01 95.61 URINE URIC ACID DECREASED | 1 0.01 95.62 UROBILIN URINE PRESENT | 1 0.01 95.63 UROGENITAL PROLAPSE | 1 0.01 95.64 URTICARIA | 14 0.14 95.78 UTERINE DISORDER | 1 0.01 95.79 UTERINE ENLARGEMENT | 1 0.01 95.80 UTERINE LEIOMYOMA | 1 0.01 95.81 UTERINE POLYP | 2 0.02 95.83 UVEITIS | 1 0.01 95.84 VAGINAL CANDIDIASIS | 2 0.02 95.86 VAGINAL DISCHARGE | 2 0.02 95.88 VAGINAL HAEMORRHAGE | 4 0.04 95.92 VAGINAL INFECTION | 3 0.03 95.95 VAGINITIS BACTERIAL | 2 0.02 95.97 VARICELLA | 1 0.01 95.98 VARICES OESOPHAGEAL | 2 0.02 96.00 VARICOCELE | 1 0.01 96.01 VASCULAR CALCIFICATION | 1 0.01 96.02 VASCULAR INJURY | 1 0.01 96.03 VASCULAR NEOPLASM | 1 0.01 96.04 VASCULAR OCCLUSION | 1 0.01 96.05 VASCULAR PSEUDOANEURYSM | 1 0.01 96.06 VASCULAR PURPURA | 1 0.01 96.07 VASCULAR SKIN DISORDER | 1 0.01 96.08 VASCULITIS | 1 0.01 96.09 VASODILATATION | 1 0.01 96.10 VASOSPASM | 1 0.01 96.11 VEIN DISORDER | 1 0.01 96.12 VENOOCCLUSIVE LIVER DISEASE | 2 0.02 96.14 VENOUS ANGIOMA OF BRAIN | 1 0.01 96.15 VENOUS STENOSIS | 1 0.01 96.16 VENOUS THROMBOSIS | 1 0.01 96.17 VENTRICULAR DYSFUNCTION | 2 0.02 96.19 VENTRICULAR DYSKINESIA | 1 0.01 96.20 VENTRICULAR EXTRASYSTOLES | 3 0.03 96.23 VENTRICULAR FIBRILLATION | 6 0.06 96.29 VENTRICULAR HYPERTROPHY | 3 0.03 96.32 VENTRICULAR HYPOKINESIA | 1 0.01 96.33 VENTRICULAR HYPOPLASIA | 2 0.02 96.35 VENTRICULAR SEPTAL DEFECT | 3 0.03 96.38 VENTRICULAR TACHYCARDIA | 4 0.04 96.42 VERTIGO | 10 0.10 96.52 VERTIGO POSITIONAL | 1 0.01 96.53 VESICAL FISTULA | 1 0.01 96.54 VESTIBULAR DISORDER | 1 0.01 96.55 VICTIM OF CRIME | 1 0.01 96.56 VIRAL INFECTION | 5 0.05 96.61 VIRAL PHARYNGITIS | 2 0.02 96.63 VISION BLURRED | 21 0.21 96.84 VISUAL ACUITY REDUCED | 16 0.16 97.00 VISUAL DISTURBANCE | 15 0.15 97.15 VISUAL FIELD DEFECT | 4 0.04 97.19 VITAMIN C DECREASED | 1 0.01 97.20 VITAMIN C DEFICIENCY | 1 0.01 97.21 VITAMIN D DEFICIENCY | 1 0.01 97.22 VITH NERVE PARALYSIS | 1 0.01 97.23 VITILIGO | 1 0.01 97.24 VITREOUS FLOATERS | 2 0.02 97.26 VITREOUS HAEMORRHAGE | 5 0.05 97.31 VOCAL CORD ATROPHY | 1 0.01 97.32 VOCAL CORD DISORDER | 2 0.02 97.34 VOCAL CORD PARALYSIS | 1 0.01 97.35 VOMITING | 96 0.96 98.31 VOMITING PROJECTILE | 1 0.01 98.32 VULVAL ULCERATION | 1 0.01 98.33 VULVOVAGINAL MYCOTIC INFECTION | 3 0.03 98.36 WALKING AID USER | 3 0.03 98.39 WALKING DISABILITY | 1 0.01 98.40 WATER INTOXICATION | 1 0.01 98.41 WEAN FROM VENTILATOR | 1 0.01 98.42 WEGENER'S GRANULOMATOSIS | 3 0.03 98.45 WEIGHT DECREASED | 37 0.37 98.82 WEIGHT FLUCTUATION | 1 0.01 98.83 WEIGHT INCREASED | 33 0.33 99.16 WEIGHT LOSS POOR | 1 0.01 99.17 WHEELCHAIR USER | 1 0.01 99.18 WHEEZING | 3 0.03 99.21 WHITE BLOOD CELL COUNT ABNORMAL | 1 0.01 99.22 WHITE BLOOD CELL COUNT DECREASED | 34 0.34 99.56 WHITE BLOOD CELL COUNT INCREASED | 15 0.15 99.71 WHITE BLOOD CELL DISORDER | 1 0.01 99.72 WOUND COMPLICATION | 1 0.01 99.73 WOUND DEBRIDEMENT | 6 0.06 99.79 WOUND DEHISCENCE | 1 0.01 99.80 WOUND HAEMORRHAGE | 1 0.01 99.81 WOUND INFECTION | 1 0.01 99.82 WOUND TREATMENT | 3 0.03 99.85 WRIST FRACTURE | 2 0.02 99.87 WRONG DRUG ADMINISTERED | 1 0.01 99.88 WRONG TECHNIQUE IN DRUG USAGE PROCESS | 7 0.07 99.95 X-RAY ABNORMAL | 2 0.02 99.97 X-RAY DENTAL | 1 0.01 99.98 XEROSIS | 1 0.01 99.99 YAWNING | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015